
<html lang="en"     class="pb-page"  data-request-id="4a114de5-f75a-4a03-b7ba-e2c928c41cf3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm200020a;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-8;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Further Structure−Activity Relationship Studies on 4-((((3S,6S)-6-Benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Identification of Compounds with Triple Uptake Inhibitory Activity as Potential Antidepressant Agents" /></meta><meta name="dc.Creator" content="Bhaskar  Gopishetty" /></meta><meta name="dc.Creator" content="Stuart  Hazeldine" /></meta><meta name="dc.Creator" content="Soumava  Santra" /></meta><meta name="dc.Creator" content="Mark  Johnson" /></meta><meta name="dc.Creator" content="Gyan  Modi" /></meta><meta name="dc.Creator" content="Solav  Ali" /></meta><meta name="dc.Creator" content="Juan  Zhen" /></meta><meta name="dc.Creator" content="Maarten  Reith" /></meta><meta name="dc.Creator" content="Aloke  Dutta" /></meta><meta name="dc.Description" content="To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol, we have carried out structur..." /></meta><meta name="Description" content="To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol, we have carried out structur..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 29, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200020a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200020a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200020a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200020a" /></link>
        
    
    

<title>Further Structure−Activity Relationship Studies on 4-((((3S,6S)-6-Benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Identification of Compounds with Triple Uptake Inhibitory Activity as Potential Antidepressant Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200020a" /></meta><meta property="og:title" content="Further Structure−Activity Relationship Studies on 4-((((3S,6S)-6-Benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Identification of Compounds with Triple Uptake Inhibitory Activity as Potential Antidepressant Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0005.jpeg" /></meta><meta property="og:description" content="To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol, we have carried out structure−activity relationship (SAR) studies to investigate the effect of alteration of aromatic substitutions and introduction of heterocyclic aromatic moieties on this molecular template. The novel compounds were tested for their affinities for the dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) in the brain by measuring their potency in inhibiting the uptake of [3H]DA, [3H]5-HT, and [3H]NE, respectively. SAR results indicate dopamine norepinephrine reuptake inhibitory (DNRI) type activity in thiophene (10g) and pyrrole (10i) derivatives. On the other hand, 3-hydroxyphenyl derivative 10f and 4-methoxyphenyl derivative 10j exhibited a triple reuptake inhibitory (TUI) activity profile, as these molecules exhibited potent uptake inhibition for all the monoamine transporters (Ki of 31.3, 40, 38.5 and Ki of 15.9, 12.9, 29.3 for DAT, SERT, and NET for 10f and 10g, respectively). Compound 10f was further evaluated in the rat forced swim test to evaluate its potential antidepressant effect. The results show significant reduction of immobility by TUI 10f at 10 mg/kg dose, indicating potential antidepressant activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200020a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200020a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200020a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200020a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200020a&amp;href=/doi/10.1021/jm200020a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 2924-2932</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200006c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200022g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Further Structure−Activity Relationship Studies on 4-((((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)methyl)phenol: Identification of Compounds with Triple Uptake Inhibitory Activity as Potential Antidepressant Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bhaskar++Gopishetty">Bhaskar Gopishetty</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart++Hazeldine">Stuart Hazeldine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Soumava++Santra">Soumava Santra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Johnson">Mark Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gyan++Modi">Gyan Modi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Solav++Ali">Solav Ali</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan++Zhen">Juan Zhen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maarten++Reith">Maarten Reith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aloke++Dutta">Aloke Dutta</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div><div class="aff-info" id="affz"><span class="aff-text"><sup>‡</sup>Department of Psychiatry and <sup>§</sup>Department of Pharmacology, New York University, New York, New York 10016, United States</span></div><div class="corresp-info">Phone: 1-313-577-1064. Fax: 1-313-577-2033. E-mail: <a href="/cdn-cgi/l/email-protection#38595c4d4c4c59784f5941565d165d5c4d"><span class="__cf_email__" data-cfemail="9cfdf8e9e8e8fddcebfde5f2f9b2f9f8e9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200020a&amp;href=/doi/10.1021%2Fjm200020a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 2924–2932</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 29, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 January 2011</li><li><span class="item_label"><b>Published</b> online</span>29 March 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 April 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200020a" title="DOI URL">https://doi.org/10.1021/jm200020a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2924%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBhaskar%2BGopishetty%252C%2BStuart%2BHazeldine%252C%2BSoumava%2BSantra%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D8%26contentID%3Djm200020a%26title%3DFurther%2BStructure%25E2%2588%2592Activity%2BRelationship%2BStudies%2Bon%2B4-%2528%2528%2528%25283S%252C6S%2529-6-Benzhydryltetrahydro-2H-pyran-3-yl%2529amino%2529methyl%2529phenol%253A%2BIdentification%2Bof%2BCompounds%2Bwith%2BTriple%2BUptake%2BInhibitory%2BActivity%2Bas%2BPotential%2BAntidepressant%2BAgents%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2932%26publicationDate%3DApril%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200020a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1000</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200020a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Further Structure−Activity Relationship Studies on 4-((((3S,6S)-6-Benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Identification of Compounds with Triple Uptake Inhibitory Activity as Potential Antidepressant Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bhaskar&quot;,&quot;last_name&quot;:&quot;Gopishetty&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;Hazeldine&quot;},{&quot;first_name&quot;:&quot;Soumava&quot;,&quot;last_name&quot;:&quot;Santra&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Gyan&quot;,&quot;last_name&quot;:&quot;Modi&quot;},{&quot;first_name&quot;:&quot;Solav&quot;,&quot;last_name&quot;:&quot;Ali&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Zhen&quot;},{&quot;first_name&quot;:&quot;Maarten&quot;,&quot;last_name&quot;:&quot;Reith&quot;},{&quot;first_name&quot;:&quot;Aloke&quot;,&quot;last_name&quot;:&quot;Dutta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;2924-2932&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200020a&quot;},&quot;abstract&quot;:&quot;To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol, we have carried out structure−activity relationship (SAR) studies to investigate the effect of alteration of aromatic substitutions and introduction of heterocyclic aromatic moieties on this molecular template. The novel compounds were tested for their affinities for the dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) in the brain by measuring their potency in inhibiting the uptake of [3H]DA, [3H]5-HT, and [3H]NE, respectively. SAR results indicate dopamine norepinephrine reuptake inhibitory (DNRI) type activity in thiophene (10g) and pyrrole (10i) derivatives. On the other hand, 3-hydroxyphenyl derivative 10f and 4-methoxyphenyl derivative 10j exhibited a triple reuptake inhibitory (TUI) activity profile, as these molecules exhibited potent uptake inhibition for all the monoamine transporters (Ki&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200020a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200020a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200020a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200020a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200020a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200020a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200020a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200020a&amp;href=/doi/10.1021/jm200020a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200020a" /></input><a href="/doi/pdf/10.1021/jm200020a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (956 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200020a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200020a%26sid%3Dliteratum%253Aachs%26pmid%3D21446715%26genre%3Darticle%26aulast%3DGopishetty%26date%3D2011%26atitle%3DFurther%2BStructure%25E2%2588%2592Activity%2BRelationship%2BStudies%2Bon%2B4-%2528%2528%2528%25283S%252C6S%2529-6-Benzhydryltetrahydro-2H-pyran-3-yl%2529amino%2529methyl%2529phenol%253A%2BIdentification%2Bof%2BCompounds%2Bwith%2BTriple%2BUptake%2BInhibitory%2BActivity%2Bas%2BPotential%2BAntidepressant%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D8%26spage%3D2924%26epage%3D2932%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jmcmar.2011.54.issue-8/production/jmcmar.2011.54.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3<i>S</i>,6<i>S</i>)-6-benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)methyl)phenol, we have carried out structure−activity relationship (SAR) studies to investigate the effect of alteration of aromatic substitutions and introduction of heterocyclic aromatic moieties on this molecular template. The novel compounds were tested for their affinities for the dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) in the brain by measuring their potency in inhibiting the uptake of [<sup>3</sup>H]DA, [<sup>3</sup>H]5-HT, and [<sup>3</sup>H]NE, respectively. SAR results indicate dopamine norepinephrine reuptake inhibitory (DNRI) type activity in thiophene (<b>10g</b>) and pyrrole (<b>10i</b>) derivatives. On the other hand, 3-hydroxyphenyl derivative <b>10f</b> and 4-methoxyphenyl derivative <b>10j</b> exhibited a triple reuptake inhibitory (TUI) activity profile, as these molecules exhibited potent uptake inhibition for all the monoamine transporters (<i>K</i><sub>i</sub> of 31.3, 40, 38.5 and <i>K</i><sub>i</sub> of 15.9, 12.9, 29.3 for DAT, SERT, and NET for <b>10f</b> and <b>10g</b>, respectively). Compound <b>10f</b> was further evaluated in the rat forced swim test to evaluate its potential antidepressant effect. The results show significant reduction of immobility by TUI <b>10f</b> at 10 mg/kg dose, indicating potential antidepressant activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Depression, especially major depression disorder, significantly affects a high percentage of the population (15−20%) and is regarded as a significant health problem. Unipolar depression is ranked as number 1 before all other somatic and psychiatric illnesses.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> It is believed that at least 20% of all individuals suffer from a depressive episode at least once in their lifetime. Depression is potentially fatal, since most sufferers consider life threatening acts and suicide.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">Selective monoamine uptake inhibitors have been used in the treatment of depression.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Among those, especially serotonin (5-HT) and norepinephrine (NE) transporter blockers have been used in the therapy for depression.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> However, in spite of developments of different arrays of antidepressants, there still remains a significant unmet need for more improved therapy, as a large number of depressed people are still refractory to the current existing therapies.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Also, a significant number of people relapse after treatment with current therapies.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Although current pharmacotherapies of depression do not address the dopaminergic component, there is ample clinical and biochemical evidence pointing toward a strong dopaminergic component in depression.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> It is hypothesized that a triple uptake inhibitor (TUI) interacting with all three monoamine transporters would display reduced side effects associated with selective serotonin reuptake inhibitors (SSRIs).<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Recently, TUIs have been shown to be potent antidepressants in animal models and therefore are being advanced as novel treatment tools offering certain advantages.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> Because of their interaction at three monoamine transporters, this class of drug could potentially provide faster onset of action. The enhanced efficacy of a TUI as an antidepressant may be due to the additional dopaminergic component, which can effectively relieve depression by activating mesocorticolimbic dopaminergic pathways, reducing anhedonia associated with a deficit in dopaminergic transmission.</div><div class="NLM_p">In recent years a number of TUIs, e.g., DOV 21,947 and PRC200-SS, have been developed and have been characterized in animal antidepressant models.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Some of these molecules are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. In our previous studies on monoamine transporters, we developed a unique pyran template as a bioisosteric extension of piperidine derivatives, which we originally synthesized for targeting the dopamine transporter (DAT).<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27">(19-27)</a> Initially, we identified unique asymmetric di- and trisubstituted pyran derivatives inhibiting uptake of all three monoamine transporters with higher potency for the 5-HT transporter (SERT) and NE transporter (NET) and modest potency for the dopamine transporter (DAT). Dual acting inhibitors as blockers of both SERT and NET as well as selective blockers for NET were also identified. Asymmetric synthesis methods have been developed by us to generate these molecules.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> The results indicated stereospecific requirement for interaction of these molecules with the monoamine transporters, as the interaction was mainly exhibited in the (−)-isomers. One of our lead TUIs, <b>1c</b> (D-161) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), was recently shown to possess antidepressant-like activity in animal studies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of known clinical and preclinical antidepressants.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular structures of lead asymmetric pyran TUIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In our current work, we extended our SAR studies further with asymmetric disubstituted pyran derivatives to understand the effect of different aromatic substitutions on affinity and selectivity for different monoamine transporters.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> describes the synthesis of the key amine intermediate <b>8</b>, which was used toward the synthesis of target compounds as shown in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Briefly, regioselective ring-opening of the (<i>R</i>)-epoxide <b>1</b> with allylmagnesium chloride in the presence of a catalytic amount of copper(I) iodide afforded alcohol <b>2</b> in good yield. Trans-vinylation of alcohol <b>2</b> with ethyl vinyl ether in the presence of mercury(II) trifluoroacetate at room temperature provided compound <b>3</b>, which was immediately converted to cyclic olefin <b>4</b> by ring-closing metathesis. Hydroboration of olefin <b>4</b> with 9-BBN in THF followed by oxidation gave an inseparable mixture containing mostly trans-isomer <b>5a</b>. The mixture of compounds <b>5a</b> and <b>5b</b> was mesylated with methanesulfonyl chloride in dichloromethane in the presence of triethylamine and separated by column chromatography to give the trans-compound <b>6a</b> in 74.7% yield and cis-compound <b>6b</b> in 12.4% yield (trans/cis = 6:1). Compound <b>6a</b> was then treated with sodium azide in DMF to give azide <b>7</b>, which was finally hydrogenated with Pd/C in methanol to obtain the optically active <i>cis</i>-amine intermediate <b>8</b> in quantitative yield.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) allylmagnesium chloride, ether, −78 °C to room temp, overnight, 82.4%; (b) ethylvinyl ether, Hg(OCOCF<sub>3</sub>)<sub>2</sub>, room temp, 4 h, 63.4%; (c) first generation Grubb's catalyst, benzene, reflux, 2 h, 67.6%; (d) (i) 9-BBN, THF, room temp, overnight; (ii) 10% NaOH, 30% H<sub>2</sub>O<sub>2</sub>, 50 °C, 1 h, 90%; (e) CH<sub>3</sub>SO<sub>2</sub>Cl, Et<sub>3</sub>N, dichloromethane, room temp, 2 h, 74.7% for <b>6a</b>, 12.4% for <b>6b</b>; (f) NaN<sub>3</sub>, DMF, 80 °C, overnight, 81.1%; (g) H<sub>2</sub>, Pd−C, MeOH, 50 psi, 2 h, quantitative yield.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) epoxide, EtOH, reflux, overnight.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RCHO, NaCNBH<sub>3</sub>, AcOH, 1,2-dichloroethane, room temp, overnight.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> outlines the synthesis of the final compounds <b>9a</b>−<b>f</b> by treating amine <b>8</b> with corresponding optically active (<i>R</i>)- and (<i>S</i>)-epoxides.</div><div class="NLM_p last">Similarly, reductive amination of amine <b>8</b> with various aldehydes furnished target compounds <b>10a</b>−<b>j</b> as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have successfully developed an improved version of the synthesis of asymmetric disubstituted pyran derivative precursor as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. This involved fewer synthetic steps to make 3,6-disubstituted compounds compared to our previous published report.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">In our previous SAR studies, we have shown that substitutions on the <i>N</i>-benzylic aromatic ring had a significant influence on the profile of monoamine uptake inhibition. One of the interesting findings from those studies was that the presence of H-bond forming functionality in the aromatic ring conferred higher potency for the NET. Compounds <b>1d</b> (D-185), <b>1b</b> (D-168), and <b>1c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with amino and hydroxyl groups at the para position exhibited a TUI profile with potent activity at the NET.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In the current SAR studies, we wanted to further explore 3,6-disubstituted compounds by introducing various aromatic substitutions and side chain expansion on the exocyclic N-atom.</div><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> describes epoxide ring-opening from 3,6-disubstituted amine precursor <b>8</b>. The rationale behind designing these compounds stems from the observation that in the GBR class of compounds such side chain extension via opening of epoxide led to development of potent molecules for DAT and SERT.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Regioselective ring-opening of different substituted (<i>R</i>)-styrene epoxides by the amine precursor <b>8</b> produced (<i>R</i>)-hydroxy compounds <b>9a</b>, <b>9c</b>, and <b>9e</b>. On the other hand, regioselective ring-opening of similar (<i>S</i>)-epoxides by the same amine precursor yielded (<i>S</i>)-hydroxy compounds <b>9b</b>, <b>9d</b>, and <b>9f</b>. None of the (<i>R</i>)-hydroxy compounds exhibited potent activity except 4-fluorophenyl substituted compound <b>9c</b> which displayed moderate potency at DAT (<i>K</i><sub>i</sub> = 71 nM). Similarly, corresponding diastereomers (<i>S</i>)-hydroxy compounds <b>9d</b> and <b>9f</b> did not exhibit much potent activity except <b>9b</b> which exhibited moderate potency at DAT (<i>K</i><sub>i</sub> = 54 nM).</div><div class="NLM_p">In our next series, we planned to systematically explore the influence of heterocyclic and substituted aromatic moieties in the disubstituted pyran template. Since the initial development of pyran derivatives, influences of N-heterocyclic substitutions have not been explored. In the starting pyridine series, 2- (<b>10a</b>), 3- (<b>10b</b>), and 4-substituted (<b>10c</b>) pyridines were designed and synthesized. Interestingly, the 4-pyridine substituted compound <b>10c</b> exhibited selective interaction with DAT (<i>K</i><sub>i</sub> of 28.3, 889, and 462 for DAT, SERT, and NET, respectively (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>)) whereas the other two pyridine compounds were weak at all three transporters. This indicates the importance of the position of the N-atom in the pyridine ring in interacting with the monoamine transporters. In our next exploration of heterocyclic aromatic moieties, thiophene derivative <b>10g</b>, furan derivative <b>10h</b>, and pyrrole derivative <b>10i</b> were designed and synthesized. Thiophene derivative <b>10g</b> and pyrrole derivative <b>10i</b> exhibited interesting dual DAT/NET potency (<i>K</i><sub>i</sub> (DAT and NET) of 41.4 and 47.2 nM for <b>10g</b> and 43.2 and 39.6 nM for <b>10i</b>), whereas furan derivative <b>10h</b> exhibited 2-fold selective potency for NET (<i>K</i><sub>i</sub> of 59.8 nM for NET vs <i>K</i><sub>i</sub> of 110 and 115 nM for DAT and SERT, respectively (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Affinity of Drugs at DAT, SERT, and NET in Rat Brain</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>K</i><sub>i</sub>, nM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">DAT uptake, [<sup>3</sup>H]DA<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SERT uptake, [<sup>3</sup>H]-5-HT<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">NET uptake, [<sup>3</sup>H]NE<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBR 12909</td><td class="colsep0 rowsep0" align="left">16.2 ± 1.6</td><td class="colsep0 rowsep0" align="left">198 ± 19</td><td class="colsep0 rowsep0" align="left">48.5 ± 7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">reboxetine</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">503 ± 61</td><td class="colsep0 rowsep0" align="left">0.826 ± 0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fluoxetine</td><td class="colsep0 rowsep0" align="left">1092 ± 98</td><td class="colsep0 rowsep0" align="left">12.2 ± 2.4</td><td class="colsep0 rowsep0" align="left">120 ± 41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">37.4 ± 3.9</td><td class="colsep0 rowsep0" align="left">14.7 ± 2.1</td><td class="colsep0 rowsep0" align="left">29.3 ± 7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">85.2 ± 8.2</td><td class="colsep0 rowsep0" align="left">25.0 ± 8.4</td><td class="colsep0 rowsep0" align="left">25.5 ± 9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left">42.0 ± 3.3</td><td class="colsep0 rowsep0" align="left">29.1 ± 3.5</td><td class="colsep0 rowsep0" align="left">30.5 ± 7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">145 ± 16</td><td class="colsep0 rowsep0" align="left">936 ± 68</td><td class="colsep0 rowsep0" align="left">162 ± 34.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">54.0 ± 8.5</td><td class="colsep0 rowsep0" align="left">796 ± 94</td><td class="colsep0 rowsep0" align="left">298 ± 45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">71.8 ± 13.6</td><td class="colsep0 rowsep0" align="left">1,140 ± 208</td><td class="colsep0 rowsep0" align="left">546 ± 97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">106 ± 28</td><td class="colsep0 rowsep0" align="left">825 ± 169</td><td class="colsep0 rowsep0" align="left">222 ± 62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">125 ± 31</td><td class="colsep0 rowsep0" align="left">1,092 ± 161</td><td class="colsep0 rowsep0" align="left">429 ± 245</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">137 ± 9</td><td class="colsep0 rowsep0" align="left">646 ± 118</td><td class="colsep0 rowsep0" align="left">299 ± 34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">209 ± 20</td><td class="colsep0 rowsep0" align="left">483 ± 63</td><td class="colsep0 rowsep0" align="left">505 ± 220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">145 ± 51</td><td class="colsep0 rowsep0" align="left">152 ± 11</td><td class="colsep0 rowsep0" align="left">353 ± 60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">28.3 ± 11.6</td><td class="colsep0 rowsep0" align="left">889 ± 61</td><td class="colsep0 rowsep0" align="left">462 ± 86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">473 ± 134</td><td class="colsep0 rowsep0" align="left">88.8 ± 21.7</td><td class="colsep0 rowsep0" align="left">232 ± 54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">200 ± 28</td><td class="colsep0 rowsep0" align="left">440 ± 96</td><td class="colsep0 rowsep0" align="left">160 ± 38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">31.3 ± 10.6</td><td class="colsep0 rowsep0" align="left">40.1 ± 4.9</td><td class="colsep0 rowsep0" align="left">38.5 ± 6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">41.4 ± 8.9</td><td class="colsep0 rowsep0" align="left">186 ± 43</td><td class="colsep0 rowsep0" align="left">47.2 ± 15.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="left">110 ± 23</td><td class="colsep0 rowsep0" align="left">115 ± 5</td><td class="colsep0 rowsep0" align="left">59.8 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10i</b></td><td class="colsep0 rowsep0" align="left">43.2 ± 1.8</td><td class="colsep0 rowsep0" align="left">141 ± 2</td><td class="colsep0 rowsep0" align="left">39.6 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10j</b></td><td class="colsep0 rowsep0" align="left">15.9 ± 1.7</td><td class="colsep0 rowsep0" align="left">12.9 ± 1.3</td><td class="colsep0 rowsep0" align="left">29.3 ± 4.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">For uptake by DAT, SERT, and NET, [<sup>3</sup>H]DA, [<sup>3</sup>H]-5-HT, and [<sup>3</sup>H]NE accumulation was measured. Results are average ± SEM of three to eight independent experiments assayed in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Not done.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selectivity of Drugs (Ratio of <i>K</i><sub>i</sub>) in Inhibiting Uptake by Monoamine Transporters</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">DAT uptake/SERT uptake<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">DAT uptake/NET uptake<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">SERT uptake/NET uptake<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">5.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">2.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">2.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">3.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">2.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">2.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">0.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">1.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">2.04</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">2.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">1.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">3.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.96</td><td class="colsep0 rowsep0" align="char" char=".">1.84</td><td class="colsep0 rowsep0" align="char" char=".">1.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10i</b></td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">1.09</td><td class="colsep0 rowsep0" align="char" char=".">3.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10j</b></td><td class="colsep0 rowsep0" align="char" char=".">1.23</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Ratio of <i>K</i><sub>i</sub> values.</p></div></div></div><div class="NLM_p">In our next series of molecules, we focused on phenyl substituted compounds. In our exploration to evaluate the effect of enhanced hydrophobicity on N-aromatic substitution, we replaced the phenyl moiety by a naphthalene ring to produce <b>10d</b>. However, such replacement only produced moderate potency for SERT (<i>K</i><sub>i</sub> = 88.8 nM). Next we wanted to explore the positional effect of the hydroxyl group on the aromatic ring in <b>1c</b>, through compounds <b>10e</b> and <b>10f</b>. The 3-hydroxyl substituted compound <b>10f</b> (<i>K</i><sub>i</sub> of 31. 40 and 38 for DAT, SERT, and NET, respectively) exhibited a TUI-like profile very similar to <b>1c</b>, whereas 2-hydroxyl substituted <b>10e</b> was much less potent at the three transporters. The low activity of <b>10e</b> might be due to the location of the hydroxyl group at the 2-position, giving rise to an unfavorable steric interaction. Next we wanted to evaluate <b>10j</b>, which is a methoxylated derivative of <b>1c</b>. The uptake inhibition results indicate higher potencies for DAT and SERT compared to <b>1c</b> in the methoxylated derivative (<i>K</i><sub>i</sub> of 15.9 and 12.9 vs 42 and 29 nM for DAT and SERT, respectively, for <b>10j</b>).</div><div class="NLM_p">Finally, we subjected one of our lead TUIs, <b>10f</b>, to the forced swim test (FST) in rats to measure its potential antidepressant effect. Extended CNS receptor screening of this compound at 10 μM indicated less than 50% inhibition with the majority of the receptor target sites and greater than 50% inhibition at a few other target sites (only marginally so in some cases; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for the data). The forced swim test has been used widely as a preclinical model for screening drugs for antidepressant activity and has been applied to characterize a broad spectrum of antidepressants.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> This assay, with some limitations, is considered a very good predictor of antidepressant activity of a test compound. On the basis of our previous experience, we chose 10 mg/kg as a moderately high dose to study the effect of this compound on immobility. It is evident from the results (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) that compound <b>10f</b> at 10 mg/kg exhibited significant reduction of immobility compared to vehicle, as did the reference drug imipramine at 15 mg/kg dose. Thus, the results suggest that compound <b>10f</b> may have antidepressant activity.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of subchronic administration of vehicle (10% β-hydroxypropylcyclodextrin solution), <b>10f</b>, and imipramine on the duration of immobility in the forced swimming test in rats. One-way ANOVA analysis demonstrated significant effect among treatments: <i>F</i>(4,95) = 13.70 (<i>P</i> < 0.008). Dunnett’s analysis showed that the effect of <b>10f</b> at 10 mg/kg dose on immobility was statistically significantly different compared to vehicle (<i>P</i> < 0.01). The effect of imipramine (15 mg/kg) on immobility was also statistically significantly different (<i>P</i> < 0.05) from vehicle. Asterisks indicate a statistically significant difference toward control group that received saline ip: (∗∗) <i>P</i> < 0.05 or 0.01. Each treatment group contained six to seven rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have carried out further SAR studies with disubstituted pyran derivatives. Introduction of exocyclic hydroxyl groups on the <i>N</i>-alkylphenyl moiety did not produce any further improvement of activity. Replacement of the phenyl ring in compound <b>1c</b> by the heterocyclic 4-pyridine moiety produced potent activity for the DAT in compound <b>10c</b>. Further replacement by five-membered heterocycles, e.g., furan, thiophene, and pyrole, produced interesting dopamine norepinephrine reuptake inhibitor (DNRI) type activity in <b>10g</b> and <b>10i</b>. Furthermore, compounds <b>10f</b> and <b>10j</b> exhibited triple uptake inhibitory activity. Finally, in the rat FST experiment, compound <b>10f</b> exhibited high efficacy in reducing immobility, indicating a potential antidepressant effect. In this regard, <b>10f</b> was more efficacious than imipramine which might indicate higher efficacy of TUI in this animal model. In the near future we plan to examine this molecule further for its potential antidepressant property.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reagents and solvents were obtained from commercial suppliers and used as received unless otherwise indicated. Dry solvents were obtained according to the standard procedures. All reactions were performed under inert atmosphere (N<sub>2</sub>) unless otherwise noted. Analytical silica gel coated TLC plates (Si 254F) were purchased from Baker Inc. and were visualized with UV light or by treatment with phosphomolybdic acid (PMA). Flash chromatography was carried out on Baker silica gel (40 μm). <sup>1</sup>H NMR and <sup>13</sup>C spectra were routinely recorded with a Varian 400 spectrometer operating at 400 and 100 MHz, respectively. The NMR solvent used was CDCl<sub>3</sub> as indicated. TMS was used as an internal standard. NMR and rotation of free bases were recorded. Salts of free bases were used for biological characterization. Elemental analyses were performed by Atlantic Microlab Inc., and results were within ±0.4% of the theoretical value.</div><div class="NLM_p">[Ring 2,5,6-<sup>3</sup>H]dopamine (38.7 Ci/mmol), [1,2-<sup>3</sup>H]serotonin (28.0 Ci/mmol), and levo-[ring-2,5,6-<sup>3</sup>H]norepinephrine (44.6 Ci/mmol) were obtained from Perkin-Elmer (Boston, MA, U.S.). Imipramine, fluoxetine, reboxetine, and GBR 12909 dihydrochloride (1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-[3-phenylpropyl]piperazine) were purchased from Sigma-Aldrich (St. Louis, MO, U.S.).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> (<i>S</i>)-1,1-Diphenylhex-5-en-2-ol (<b>2</b>)</h3><div class="NLM_p last">To a stirred solution of (<i>R</i>)-2-benzhydryloxirane<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (4.5 g, 21.40 mmol) in anhydrous diethyl ether (90 mL) was added copper(I) iodide (0.41 g, 2.14 mmol) and allylmagnesium chloride (13.37 mL, 2 M solution in tetrahydrofuran, 26.75 mmol) at −78 °C. After being stirred overnight at room temperature under nitrogen atmosphere, the reaction mixture at 0 °C was quenched by addition of saturated NH<sub>4</sub>Cl solution (50 mL) and extracted with ethyl acetate (3 × 75 mL). The combined organic layers were washed with water (50 mL), brine (50 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, and solvent was removed under reduced pressure. The crude residue was purified by silica gel column chromatography using 10% ethyl acetate in hexanes to give compound <b>2</b> (4.45 g, 82%) as a thick colorless syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.44−1.64 (m, 3H), 2.12−2.21 (m, 1H), 2.25−2.34 (m, 1H), 3.89 (d, <i>J</i> = 8.4 Hz, 1H), 4.34−4.40 (m, 1H), 4.93−5.04 (m, 2H), 5.72−5.83 (m, 1H), 7.18−7.42 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 30.41, 34.42, 59.14, 73.40, 115.13, 126.82, 127.14, 128.50, 128.92, 129.05, 129.09, 138.72, 141.69, 142.60.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> (<i>S</i>)-(2-(Vinyloxy)hex-5-ene-1,1-diyl)dibenzene (<b>3</b>)</h3><div class="NLM_p last">To a stirred solution of alcohol <b>2</b> (2.6 g, 10.30 mmol) in excess of ethyl vinyl ether (100 mL) was added mercury(II) trifluoroacetate (0.88 g, 2.06 mmol) at room temperature, and stirring was continued for 4 h under a nitrogen atmosphere. The solvent was removed under reduced pressure at room temperature. The crude product was dissolved in 5% ethyl acetate in hexanes and filtered through a basic alumina pad quickly, and the filtrate was concentrated under reduced pressure at room temperature to give product <b>3</b> (1.82 g, 63%) as a thick light-yellow syrup. The unreacted starting material <b>2</b> (0.65 g, 25%) was also recovered by washing the used basic alumina pad with 15% ethyl acetate in hexanes. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.55−1.72 (m, 2H), 2.05−2.22 (m, 2H), 3.83 (dd, <i>J</i> = 1.6, 6.4 Hz, 1H), 4.10 (d, <i>J</i> = 7.6 Hz, 1H), 4.20 (dd, <i>J</i> = 1.6, 14.0 Hz, 1H), 4.45 (dt, <i>J</i> = 4.0, 7.6 Hz, 1H), 4.80−5.06 (m, 2H), 5.68−5.78 (m, 1H), 6.12 (dd, <i>J</i> = 6.4, 14.0 HZ, 1H), 7.16−7.36 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 29.70, 32.57, 56.21, 82.10, 88.20, 115.45, 126.72, 126.84, 128.56, 128.81, 128.85, 129.24, 138.22, 141.62, 142.28, 152.23.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> (<i>S</i>)-2-Benzhydryl-3,4-dihydro-2<i>H</i>-pyran (<b>4</b>)</h3><div class="NLM_p last">To a stirred solution of compound <b>3</b> (1.65 g, 5.93 mmol) in anhydrous benzene (80 mL) was added Grubb’s (first generation) catalyst (0.24 g, 0.3 mmol) at room temperature under nitrogen atmosphere. The reaction mixture was slowly heated to reflux, and the refluxing was continued for 2 h. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure. The crude residue was purified by column chromatography using 5% ethyl acetate in hexanes and recrystallized in hexanes to give compound <b>4</b> (1 g, 68%) as a white solid. Mp: 68−70 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.52−1.62 (m, 1H), 1.72−1.82 (m, 1H), 1.92−2.10 (m, 2H), 4.05 (d, <i>J</i> = 8.8 Hz, 1H), 4.57 (dt, <i>J</i> = 2.4, 9.2 Hz, 1H), 4.67−4.72 (m, 1H), 6.35 (d, <i>J</i> = 6.0 Hz, 1H), 7.16−7.42 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 20.01, 26.49, 56.46, 76.64, 100.86, 126.66, 126.85, 128.60, 128.70, 128.88, 142.12, 142.42, 144.06.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-ol (Mixture of <b>5a</b> and <b>5b</b>)</h3><div class="NLM_p last">To a stirred solution of compound <b>4</b> (2.8 g, 11.18 mmol) in anhydrous THF (10 mL) was added 9-BBN (56 mL, 0.5 M solution in tetrahydrofuran, 27.96 mmol) under a nitrogen atmosphere. After being stirred overnight at room temperature, the reaction mixture was cooled to 0 °C, quenched by the addition of ethanol (15 mL), and stirred for 10 min. Next, aqueous 10% NaOH solution (15 mL) and 30% H<sub>2</sub>O<sub>2</sub> (10 mL) were added, and the resulting solution was heated to 50 °C for 1 h. After cooling to room temperature, the reaction mixture was treated with water (40 mL) and extracted with ethyl acetate (3 × 75 mL). The combined organic layers were washed with water (40 mL), brine (40 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude residue was purified by column chromatography using 25% ethyl acetate in hexanes to give mixture of inseparable compounds <b>5a</b> and <b>5b</b> (2.7 g, 90%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.34−1.45 (m, 3H), 1.53−1.61 (m, 1H), 2.01−2.09 (m, 1H), 3.14 (t, <i>J</i> = 10.0 Hz, 1H), 3.62−3.70 (m, 1H), 3.91 (d, <i>J</i> = 9.2 Hz, 1H), 3.95−4.04 (m, 2H), 7.16−7.37 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 29.68, 33.01, 57.55, 66.24, 73.18, 79.09, 126.68, 126.92, 128.73, 128.78, 128.81, 128.86, 128.99, 142.57, 142.64, 142.96.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (3<i>R</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl Methanesulfonate (<b>6a</b>)</h3><div class="NLM_p last">To an ice-cooled stirred mixture of compounds <b>5a</b> and <b>5b</b> (2.7 g, 10.06 mmol) and triethylamine (2.8 mL, 20.12 mmol) in anhydrous dichloromethane (60 mL) was added methanesulfonyl chloride (1.17 mL, 15.09 mmol) under a nitrogen atmosphere. After being stirred for 2 h at room temperature, the reaction mixture was extracted with ethyl acetate (3 × 75 mL) and water (40 mL). The combined organic layers were washed with water (40 mL), brine (40 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The residue was purified by column chromatography using 25% ethyl acetate in hexanes to elute the trans compound <b>6a</b> (2.6 g, 75%) first as a white solid followed by cis compound <b>6b</b> (0.43 g, 12%) as a white solid. Spectral data for <b>6a</b>. Mp: 110−112 °C. [α]<sup>25</sup><sub>D</sub> (−)48.4° (<i>c</i> 0.5, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.42−1.52 (m, 1H, H-5ax), 1.62−1.78 (m, 2H, H-4ax, H-5eq), 2.21−2.30 (m, 1H, H-4eq), 2.99 (s, 3H, CH<sub>3</sub>), 3.37 (t, <i>J</i> = 10.4 Hz, 1H, H-2ax), 3.89 (d, <i>J</i> = 8.8 Hz, 1H, Ph<sub>2</sub>CH), 4.02 (dt, <i>J</i> = 2.0, 9.2 Hz, 1H, H-6ax), 4.10−4.18 (m, 1H, H-2eq), 4.58−4.66 (m, 1H, H-3ax), 7.14−7.32 (m, 10H, aromatic). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 29.51, 30.58, 38.68, 57.12, 69.87, 75.27, 79.04, 126.73, 126.96, 128.59, 128.65, 128.68, 128.93, 141.97, 142.34.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (2<i>S</i>,5<i>S</i>)-5-Azido-2-benzhydryltetrahydro-2<i>H</i>-pyran (<b>7</b>)</h3><div class="NLM_p last">To a stirred solution of compound <b>6a</b> (2.5 g, 7.22 mmol) in DMF (60 mL) was added sodium azide (2.35 g, 36.08 mmol). After being stirred overnight at 80 °C, the reaction mixture was cooled to room temperature, treated with water (40 mL), and extracted with ethyl ether (3 × 75 mL). The combined organic layers ware washed with water (40 mL), brine (40 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude residue was purified by column chromatography using 5% ethyl acetate in hexanes to give compound <b>7</b> (1.72 g, 81%) as a white solid. Mp: 93−95 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.32−1.38 (m, 1H), 1.59−1.70 (m, 1H), 1.73−1.82 (m, 1H), 1.94−2.20 (m, 1H), 3.52−3.57(m, 1H), 3.63 (dd, <i>J</i> = 1.6, 12.0 Hz, 1H), 3.95−4.10 (m, 3H), 7.16−7.38 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.43, 27.68, 55.58, 57.55, 69.80, 79.45, 126.56, 126.81, 128.57, 128.64, 128.73, 128.84, 142.23.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-amine (<b>8</b>)</h3><div class="NLM_p last">Azide <b>7</b> (0.65 g, 2.21 mmol) in methanol (40 mL) was hydrogenated (50 psi) in the presence of 10% Pd−C (65 mg, 10 wt %) for 2 h. The reaction mixture was filtered through a short bed of Celite, and the solvent was removed under reduced pressure to afford amine <b>8</b> (0.65 g) as a light yellow solid in quantitative yield. The product was pure enough for continuation to the next step. Mp: 92−94 °C. [α]<sup>25</sup><sub>D</sub> (−)76.8° (<i>c</i> 1.0, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.24−1.44 (m, 3H), 1.52−1.62 (m, 1H), 1.63−1.80 (m, 2H), 2.89 (br s, 1H), 3.62−3.66 (m, 1H), 3.74−3.80 (m, 1H), 3.96 (d, <i>J</i> = 8.8 Hz, 1H), 4.04 (dt, <i>J</i> = 2.4, 8.8 Hz, 1H), 7.12−7.37 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.86, 31.06, 45.55, 57.58, 73.92, 79.60, 126.50, 126.69, 128.56, 128.72, 128.76, 142.40, 142.65.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Procedure A. (<i>R</i>)-2-((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-ylamino)-1-phenylethanol (<b>9a</b>)</h3><div class="NLM_p last">A mixture of amine <b>8</b> (50 mg, 0.19 mmol) and (<i>R</i>)-2-phenyloxirane (27 mg, 0.22 mmol) in anhydrous ethanol (3 mL) was refluxed under nitrogen atmosphere overnight. The solvent was removed under reduced pressure and the crude residue was purified by column chromatography using 3% methanol in ethyl acetate to afford compound <b>9a</b> (40 mg, 56%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28−1.34 (m, 1H), 1.45−1.55 (m, 1H), 1.67 (tt, <i>J</i> = 4.0, 13.6 Hz, 1H), 1.82−1.92 (m, 1H), 2.57 (dd, <i>J</i> = 9.6, 12.4 Hz, 1H), 2.65 (br s, 1H), 2.91 (dd, <i>J</i> = 3.6, 12.4 Hz, 1H), 3.58 (dd, <i>J</i> = 1.2, 11.6 Hz, 1H), 3.90−3.98 (m, 2H), 4.05 (dt, <i>J</i> = 2.0, 10.4 Hz, 1H), 4.63 (dd, <i>J</i> = 3.6, 9.6 Hz, 1H), 7.12−7.40 (m, 15H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.63, 26.64, 51.16, 53.74, 57.12, 68.84, 71.83, 79.11, 125.66, 125.97, 126.28, 127.49, 128.02, 128.14, 128.20, 128.29, 141.91, 142.00, 142.28. [α]<sup>25</sup><sub>D</sub> (−)100.6° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 275−277 °C. Anal. (C<sub>26</sub>H<sub>29</sub>NO<sub>2</sub>·HCl) C, H, N.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (<i>S</i>)-2-((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-ylamino)-1-phenylethanol (<b>9b</b>)</h3><div class="NLM_p last">Amine <b>8</b> (0.1 g, 0.37 mmmol) was treated with (<i>S</i>)-2-phenyloxirane (45 mg, 0.37 mmol) in anhydrous ethanol (5 mL) using procedure A. The residue was purified by column chromatography using 4% methanol in ethyl acetate to afford compound <b>9b</b> (90 mg, 62%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.26−1.34 (m, 1H), 1.48−1.59 (m, 1H), 1.67 (tt, <i>J</i> = 4.0, 13.6 Hz, 1H), 1.92−1.99 (m, 1H), 2.65 (dd, <i>J</i> = 9.2, 12.0 Hz, 1H), 2.74 (br s, 1H), 3.05 (dd, <i>J</i> = 3.2, 12.0 Hz, 1H), 3.48−3.52 (m, 1H), 3.96−4.06 (m, 4H), 4.78 (dd, <i>J</i> = 2.8, 9.2 Hz, 1H), 7.12−7.38 (m, 15H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.82, 26.47, 51.53, 54.37, 57.12, 70.12, 70.99, 79.30, 125.72, 126.23, 126.50, 127.51, 128.28, 128.37, 128.40, 128.47, 128.53, 141.92, 142.04, 142.09. [α]<sup>25</sup><sub>D</sub> (−)40.6° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 215−217 °C. Anal. (C<sub>26</sub>H<sub>29</sub>NO<sub>2</sub>·HCl) C, H, N.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>R</i>)-2-(((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)-1-(4-fluorophenyl)ethanol (<b>9c</b>)</h3><div class="NLM_p last">Amine <b>8</b> (60 mg, 0.22 mmol) was treated with (<i>R</i>)-2-(4-fluorophenyl)oxirane (35 mg, 0.25 mmol) in anhydrous ethanol (3 mL) using procedure A. The residue was purified by silica gel column chromatography using 3% methanol in ethyl acetate as the eluent to afford compound <b>9c</b> (51 mg, 59%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.20−1.56 (m, 2H), 1.56−1.76 (m, 1H), 1.86−2.04 (m, 1H), 2.62−2.72 (m, 1H), 2.75 (s, 1H), 2.84 (dd, <i>J</i> = 3.5, 12.0 Hz, 1H), 3.25−3.65 (m, 3H), 3.82−3.94 (m, 2H), 3.97−4.09 (m, 1H), 4.75 (dd, <i>J</i> = 3.5, 9.4 Hz, 1H), 6.90−7.05 (m, 2H), 7.06−7.36 (m, 12H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.8, 27.4, 51.0, 54.3, 57.2, 69.7, 71.2, 79.3, 114.9, 115.2, 126.2, 126.4, 127.3, 127.4, 128.3, 128.4, 138.1, 141.9, 142.0, 160.9, 163.3. [α]<sup>25</sup><sub>D</sub> (−)54.6° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 260−265 °C. Anal. (C<sub>26</sub>H<sub>28</sub>NO<sub>2</sub>F·HCl) C, H, N.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (<i>S</i>)-2-(((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)-1-(4-fluorophenyl)ethanol (<b>9d</b>)</h3><div class="NLM_p last">Amine <b>8</b> (60 mg, 0.22 mmol) was treated with (<i>S</i>)-2-(4-fluorophenyl)oxirane (35 mg, 0.25 mmol) in anhydrous ethanol (3 mL) using procedure A. The residue was purified by silica gel column chromatography using 3% methanol in ethyl acetate as the eluent to afford compound <b>9d</b> (48 mg, 56%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.17−1.38 (m, 2H), 1.56−1.76 (m, 1H), 1.96−2.08 (m, 1H), 2.75 (t from dd, <i>J</i> = 10.0 Hz, 1H), 2.88 (br s, 1H), 3.10 (dd, <i>J</i> = 2.3, 12.0 Hz, 1H), 3.44 (d, <i>J</i> = 12.3 Hz, 1H), 4.02−4.12 (m, 3H), 4.95 (d, <i>J</i> = 9.1 Hz, 1H), 5.63 (br s, 1H), 6.93−7.04 (m, 2H), 7.13−7.40 (m, 12H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.4, 25.4, 52.0, 54.1, 56.8, 69.2, 69.5, 69.6, 79.3, 115.1, 115.3, 126.2, 126.5, 127.3, 127.4, 128.2, 128.3, 128.4, 128.5, 136.9, 137.0, 141.8, 141.9, 160.9, 163.4. [α]<sup>25</sup><sub>D</sub> (−)34.6° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 248−256 °C. Anal. (C<sub>26</sub>H<sub>28</sub>NO<sub>2</sub>F·HCl·0.4H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>R</i>)-2-(((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)-1-(3-methoxyphenyl) ethanol (<b>9e</b>)</h3><div class="NLM_p last">Amine <b>8</b> (60 mg, 0.22 mmol) was treated with (<i>R</i>)-2-(3-methoxyphenyl)oxirane (38 mg, 0.25 mmol) in anhydrous ethanol (3 mL) using procedure A. The residue was purified by silica gel column chromatography using 3% methanol in ethyl acetate as the eluent to afford compound <b>9e</b> (55 mg, 59%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.76−0.89 (m, 1H), 1.10−1.50 (m, 3H), 1.56−1.74 (m, 1H), 1.80−1.98 (m, 1 H), 2.63−2.73 (m, 2H), 2.82 (dd, <i>J</i> = 3.5, 12.0 Hz, 1H), 3.41 (br s, 2H), 3.56 (dd, <i>J</i> = 1.5, 12.0 Hz, 1H), 3.74 (s, 3H), 3.82−3.96 (m, 2H), 3.96−4.07 (m, 1H), 4.69 (dd, <i>J</i> = 3.5, 9.1 Hz, 1H), 6.73−6.80 (m, 1H), 6.84−6.91 (m, 2H), 7.07−7.32 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.7, 26.9, 51.3, 53.9, 55.1, 57.1, 68.9, 71.2, 79.3, 111.0, 113.2, 118.0, 126.2, 126.4, 128.2, 128.4, 129.3, 141.8, 143.6, 159.6. [α]<sup>25</sup><sub>D</sub> (−)69.5° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 140−150 °C. Anal. (C<sub>27</sub>H<sub>31</sub>NO<sub>3</sub>·HCl·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>S</i>)-2-(((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)-1-(3-methoxyphenyl)ethanol (<b>9f</b>)</h3><div class="NLM_p last">Compound <b>8</b> (0.18 g, 0.67 mmol) was treated with (<i>S</i>)-2-(3-methoxyphenyl)oxirane (0.1 g, 0.67 mmol) in anhydrous ethanol (10 mL) using procedure A. The residue was purified by column chromatography using 5% methanol in ethyl acetate to afford compound <b>9f</b> (0.16 g, 57%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.24−1.34 (m, 2H), 1.42−1.56 (m, 1H), 1.65 (tt, <i>J</i> = 4.0, 13.2 Hz, 1H), 1.90−1.98 (m, 1H), 2.62 (dd, <i>J</i> = 9.6, 12.4 Hz, 1H), 2.71 (br s, 1H), 3.03 (dd, <i>J</i> = 3.2, 12.4 Hz, 1H), 3.48−3.54 (m, 1H), 3.80 (s, 3H), 3.94−4.08 (m, 3H), 4.72 (dd, <i>J</i> = 2.8, 9.2 Hz, 1H), 6.81 (dd, <i>J</i> = 2.4, 8.0 Hz, 1H), 6.90−6.96 (m, 2H), 7.12−7.34 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.15, 26.92, 51.68, 54.60, 55.50, 57.46, 70.56, 71.37, 79.58, 111.25, 113.47, 118.29, 126.51, 126.77, 128.56, 128.66, 128.72, 128.81, 129.65, 142.32, 142.39, 144.14, 159.99. [α]<sup>25</sup><sub>D</sub> (−)53.2° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 210−212 °C. Anal. (C<sub>27</sub>H<sub>31</sub>NO<sub>3</sub>·HCl) C, H, N.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Procedure B. (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(pyridin-2-ylmethyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10a</b>)</h3><div class="NLM_p last">To a stirred solution of amine <b>8</b> (60 mg, 0.22 mmol) and 2-pyridinecarboxaldehyde (21 μL, 0.22 mmol) in 1,2-dichloroethane (6 mL) was added glacial acetic acid (13 μL, 0.22 mmol). After the mixture was stirred for 30 min, NaCNBH<sub>3</sub> (28 mg, 0.44 mmol) was added portionwise followed by methanol (1 mL) and the mixture was stirred overnight at room temperature. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> solution at 0 °C and extracted with ethyl acetate (3 × 75 mL). The combined organic layers were washed with water, brine and dried over Na<sub>2</sub>SO<sub>4</sub>, and solvent was removed under reduced pressure. Crude product was purified by column chromatography using 3% methanol in dichloromethane to give compound <b>10a</b> (45 mg, 56%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28−1.36 (m, 1H), 1.50−1.74 (m, 1H), 1.91−2.04 (m, 1H), 2.74 (s, 1H), 3.28 (br s, 1H), 3.58 (dd, <i>J</i> = 1.8, 12.0 Hz, 1H), 3.85−4.14 (m, 5H), 7.07−7.42 (m, 12H), 7.62 (t, <i>J</i> = 7.6 Hz, 1H), 8.52 (d, <i>J</i> = 3.9 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.0, 27.2, 51.1, 52.1, 57.0, 70.1, 79.3, 121.9, 122.1, 126.1, 126.4, 128.2, 128.5, 136.5, 142.2, 142.3, 149.1, 159.3. [α]<sup>25</sup><sub>D</sub> (−)65.0° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 220−230 °C. Anal. (C<sub>24</sub>H<sub>26</sub>N<sub>2</sub>O·2HCl) C, H, N.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(pyridin-3-ylmethyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10b</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 3-pyridinecarboxaldehyde (21 μL, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and NaCNBH<sub>3</sub> (28 mg, 0.44 mmol)) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 3% methanol in dichloromethane to afford compound <b>10b</b> (45 mg, 56%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.24−1.36 (m, 2H), 1.48−1.70 (m, 2H), 1.90−1.98 (m, 1H), 2.64 (br s, 1H), 3.56 (dd, <i>J</i> = 1.6, 12.0 Hz, 1H), 3.81 (br s, 2H), 3.94−4.10 (m, 3H), 7.10−7.38 (m, 11H), 7.72 (d, <i>J</i> = 7.2 Hz, 1H), 8.50 (d, <i>J</i> = 3.6 Hz, 1H), 8.54 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.35, 27.55, 48.26, 50.62, 57.50, 70.37, 79.53, 123.64, 126.52, 126.72, 128.56, 128.72, 128.75, 128.77, 136.11, 142.34, 142.57, 148.70, 149.92. [α]<sup>25</sup><sub>D</sub> (−)77.2° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 258−260 °C. Anal. (C<sub>24</sub>H<sub>26</sub>N<sub>2</sub>O·2HCl) C, H, N.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(pyridin-4-ylmethyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10c</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 4-pyridinecarboxaldehyde (21 μL, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and NaCNBH<sub>3</sub> (28 mg, 0.44 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 3% methanol in dichloromethane to afford compound <b>10c</b> (46 mg, 58%) as a thick syrup. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 1.35−1.43 (m, 1H), 1.46−1.60 (m, 1H), 1.72 (tt, <i>J</i> = 4.0, 13.4 Hz, 1H), 1.86−1.95 (m, 1H), 2.58 (s, 1H), 3.61 (dd, <i>J</i> = 1.2, 11.6 Hz, 1H), 3.89−4.02 (m, 4H), 4.06−4.13 (m, 1H), 7.16−7.40 (m, 10H), 7.67 (d, <i>J</i> = 6.1 Hz, 2H), 8.48 (d, <i>J</i> = 6.1 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 25.1, 27.5, 49.1, 50.9, 57.4, 70.2, 79.3, 124.9, 126.3, 126.5, 128.3, 128.4, 128.6, 128.5, 141.9, 142.1, 146.7, 157.6. [α]<sup>25</sup><sub>D</sub> (−)69.5° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 224−230 °C. Anal. (C<sub>24</sub>H<sub>26</sub>N<sub>2</sub>O·1.8HCl) C, H, N.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(naphthalen-1-ylmethyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10d</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 1-naphthaldehyde (30 μL, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and NaCNBH<sub>3</sub> (28 mg, 0.44 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 3% methanol in dichloromethane to afford compound <b>10d</b> (51 mg, 56%) as a thick syrup. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 1.33−1.41 (m, 1H), 1.55−1.66 (m, 1H), 1.73 (tt, <i>J</i> = 4.0, 13.4 Hz, 1H), 1.99−2.08 (m, 1H), 3.63 (dd, <i>J</i> = 1.2, 11.6 Hz, 1H), 4.01 (d, <i>J</i> = 8.9 Hz, 1H), 4.07−418 (m, 2H), 4.28 (dd, <i>J</i> = 13.1, 37.5 Hz, 2H), 7.17−7.35 (m, 8 H), 7.37−7.58 (m, 6 H), 7.81 (d, <i>J</i> = 8.2 Hz, 1H), 7.90 (d, <i>J</i> = 7.6 Hz, 1H), 8.19 (d, <i>J</i> = 8.2 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 25.3, 27.7, 48.4, 50.9, 57.2, 70.1, 79.3, 123.7, 125.4, 125.9, 126.0, 126.2, 126.4, 127.7, 128.3, 128.4, 128.5, 128.6, 131.8, 133.8, 135.8, 142.2, 142.4. [α]<sup>25</sup><sub>D</sub> (−)69.5° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 140−150 °C. Anal. (C<sub>29</sub>H<sub>29</sub>NO·HCl·0.4H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-(((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-ylamino)methyl)phenol (<b>10e</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 2-hydroxybenzaldehyde (24 μL, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and NaCNBH<sub>3</sub> (28 mg, 0.44 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 2% methanol in dichloromethane to afford compound <b>10e</b> (65 mg, 77%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.34−1.52 (m, 2H), 1.68 (tt, <i>J</i> = 4.0, 13.6, 1H), 1.90−2.00 (m, 1H), 2.70 (br s, 1H), 3.54−3.60 (m, 1H), 3.90−3.96 (m, 2H), 4.00−4.12 (m, 3H), 6.78 (t, <i>J</i> = 7.6 Hz, 1H), 6.85 (d, <i>J</i> = 8.0 Hz, 1H), 6.97 (d, <i>J</i> = 6.8 Hz, 1H), 7.14−7.38 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.48, 27.28, 49.61, 49.80, 57.89, 69.72, 79.69, 116.69, 119.20, 112.50, 126.63, 126.85, 128.58, 128.67, 128.86, 129.01, 142.21, 142.27, 158.72. [α]<sup>25</sup><sub>D</sub> (−)86.2° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 315−317 °C (dec). Anal. (C<sub>25</sub>H<sub>27</sub>NO<sub>2</sub>·HCl·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-((((3<i>S</i>,6<i>S</i>)-6-Benzhydryltetrahydro-2<i>H</i>-pyran-3-yl)amino)methyl)phenol (<b>10f</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 3-hydroxybenzaldehyde (24 μL, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and Na(OAc)<sub>3</sub>BH (84 mg, 0.44 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 2% methanol in dichloromethane to afford compound <b>10f</b> (64 mg, 76%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.29−1.39 (m, 1H), 1.44−1.58 (m, 1H), 1.68 (tt, <i>J</i> = 4.3, 13.7 Hz, 1H), 2.05−2.11 (m 1H), 2.82 (br s, 1H), 3.31−3.35 (m, 1H), 3.52 (d, <i>J</i> = 12.5 Hz, 1H), 3.82 (dd, <i>J</i> = 13.1, 29.9 Hz, 2H), 3.94 (d, <i>J</i> = 9.2 Hz, 1H), 3.99−4.09 (m, 2H), 6.68 (d, <i>J</i> = 7.3 Hz, 1H), 6.74 (d, <i>J</i> = 8.2 Hz, 1H), 6.96 (s, 1H), 7.09−7.31 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.5, 25.8, 49.2, 49.9, 56.9, 67.9, 79.4, 115.4, 115.7, 120.0, 126.3, 126.5, 128.2, 128.5, 129.8, 141.7, 141.8, 157.4. [α]<sup>25</sup><sub>D</sub> (−)55.4° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 190−200 °C. Anal. (C<sub>25</sub>H<sub>27</sub>NO<sub>2</sub>·HCl·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(thiophen-2-ylmethyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10g</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 2-thiophenecarboxaldehyde (25 mg, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and NaCNBH<sub>3</sub> (18 mg, 0.29 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 3% methanol in dichloromethane to afford compound <b>10g</b> (65 mg, 79%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.24−1.34 (m, 1H), 1.44−1.58 (m, 1H), 1.64 (tt, <i>J</i> = 4.0, 13.2 Hz, 1H), 1.86−1.94 (m, 1H), 2.69 (br s, 1H), 3.55 (dd, <i>J</i> = 2.0, 12.0 Hz, 1H), 3.92−4.08 (m, 6H), 6.88−6.91 (m, 1H), 6.92−6.95 (m, 1H), 7.14−7.36 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.51, 27.87, 45.85, 50.22, 57.60, 70.43, 79.56, 124.53, 124.75, 126.54, 126.74, 126.83, 128.63, 128.78, 128.82, 142.49, 142.68, 145.09. [α]<sup>25</sup><sub>D</sub> (−)78.4° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 256−258 °C. Anal. (C<sub>23</sub>H<sub>25</sub>NOS·HCl·0.1H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(furan-2-ylmethyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10h</b>)</h3><div class="NLM_p last">Compound <b>8</b> (50 mg, 0.19 mmol) was reacted with furfural (18 mg, 0.19 mmol), glacial acetic acid (11 μL, 0.19 mmol), and NaCNBH<sub>3</sub> (24 mg, 0.37 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using 45% ethyl acetate in hexanes to afford compound <b>10h</b> (45 mg, 69%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28−1.34 (m, 1H), 1.45−1.58 (m, 1H), 1.59−1.74 (m, 2H), 1.84−1.94 (m, 1H), 2.65 (br s, 1H), 3.55 (dd, <i>J</i> = 2.0, 12.0 Hz, 1H), 3.77 (dd, <i>J</i> = 14.4, 22.8 Hz, 2H), 3.90−4.00 (m, 2H), 4.02−4.10 (m, 1H), 6.15 (d, <i>J</i> = 2.8 Hz, 1H), 6.30 (t, <i>J</i> = 2.8 Hz, 1H), 7.10−7.40 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.36, 27.82, 43.76, 50.50, 57.42, 70.30, 79.51, 106.96, 110.32, 126.47, 126.67, 128.55, 128.70, 128.72, 128.76, 141.98, 142.49, 142.65, 154.27. [α]<sup>25</sup><sub>D</sub> (−)75.4° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 228−230 °C. Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>2</sub>·HCl·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (3<i>S</i>,6<i>S</i>)-<i>N</i>-((1<i>H</i>-Pyrrol-2-yl)methyl)-6-benzhydryltetrahydro-2<i>H</i>-pyran-3-amine (<b>10i</b>)</h3><div class="NLM_p last">Compound <b>8</b> (50 mg, 0.19 mmol) was reacted with pyrrole-2-carboxaldehyde (18 mg, 0.19 mmol), glacial acetic acid (11 μL, 0.19 mmol), and NaCNBH<sub>3</sub> (24 mg, 0.37 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude product was purified by column chromatography using 5% methanol in ethyl acetate to afford compound <b>10i</b> (50 mg, 77%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.32−1.36 (m, 1H), 1.64−1.68 (m, 2H), 1.96−2.00 (m, 1H), 2.72 (br s, 1H), 3.46 (d, <i>J</i> = 12.4 Hz, 1H), 3.88−4.08 (m, 5H), 4.99 (br s, 1H), 6.07 (br s, 1H), 6.14 (br s, 1H), 6.77 (br s, 1H), 7.10−7.36 (m, 10H), 9.48 (br s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.11, 26.55, 43.13, 50.30, 57.43, 69.54, 79.63, 107.93, 108.22, 118.58, 126.48, 126.79, 127.41, 128.55, 128.67, 128.78, 128.83, 142.34, 142.49. [α]<sup>25</sup><sub>D</sub> (−)77.8° (<i>c</i> 0.5, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 234−236 °C. Anal. (C<sub>23</sub>H<sub>26</sub>N<sub>2</sub>O·HCl·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (3<i>S</i>,6<i>S</i>)-6-Benzhydryl-<i>N</i>-(4-methoxybenzyl)tetrahydro-2<i>H</i>-pyran-3-amine (<b>10j</b>)</h3><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.22 mmol) was reacted with 4-methoxybenzaldehyde (31 mg, 0.22 mmol), glacial acetic acid (13 μL, 0.22 mmol), and NaCNBH<sub>3</sub> (28 mg, 0.44 mmol) in 1,2-dichloroethane (6 mL) using procedure B. The crude residue was purified by column chromatography using ethyl acetate to afford compound <b>10j</b> (40 mg, 46%) as a thick syrup. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28−1.36 (m, 1H), 1.50−1.70 (m, 2H), 1.81 (br s, 1H), 1.90−1.98 (m, 1H), 2.65 (br s, 1H), 3.57 (d, <i>J</i> = 11.6 Hz, 1H), 3.73 (dd, <i>J</i> = 12.8, 24.8 Hz, 2H), 3.82 (s, 3H), 3.96−4.10 (m, 3H), 6.88 (d, <i>J</i> = 8.8 Hz, 2H), 7.16−7.40 (m, 12H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 25.45, 27.84, 50.40, 50.46, 55.51, 57.45, 70.49, 79.49, 114.01, 126.46, 126.64, 128.52, 128.73, 128.75, 128.82, 129.43, 132.96, 142.48, 142.76, 158.82. [α]<sup>25</sup><sub>D</sub> (−) 67.3° (<i>c</i> 1, MeOH). The product was converted into the corresponding hydrochloride salt. Mp: 136−138 °C. Anal. (C<sub>26</sub>H<sub>29</sub>NO<sub>2</sub>·HCl·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_23_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> In Vitro Experiments</h3><div id="sec5_23_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Monoamine Transport Inhibition</h4><div class="NLM_p last">The ability of test compounds to inhibit substrate uptake by rat monoamine transporters was monitored as described by us previously.<a onclick="showRef(event, 'ref28 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref32">(28, 32)</a> Briefly, uptake of [<sup>3</sup>H]dopamine by DAT was measured in rat striatum, and uptake of [<sup>3</sup>H]serotonin by SERT and [<sup>3</sup>H]norepinephrine by NET was monitored in rat cerebral cortex. At least five triplicate concentrations of each test compound were studied, spaced evenly around the IC<sub>50</sub>. IC<sub>50</sub> was estimated by nonlinear computer curve-fitting procedures and converted to <i>K</i><sub>i</sub> with the Cheng−Prusoff equation, as we described previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec5_23_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> CNS Receptor Screening</h4><div class="NLM_p">Compound <b>10f</b> was characterized in several CNS receptor binding assays to assess the selectivity and specific interactions of <b>10f</b> with the monoamine transporters. The assays were carried out generously by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract NO1MH32004 (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth, MD, Ph.D., at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda, MD, U.S. (<a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a>).</div><div class="NLM_p last">Compound <b>10f</b> was evaluated in primary binding assays targeting, among others, cloned human dopamine receptor subtypes, serotonin receptor subtypes, α-adrenergic receptors, and opioid receptors. The description of all receptors targeted and corresponding radioligand used is provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The default concentration for primary binding experiments was 10 μM. Compounds with inhibition of >50% in the primary assay were moved into the secondary assay with full concentration curves of the test compound in order to calculate the <i>K</i><sub>i</sub> value for inhibition. For experimental details refer to the PDSP Web site <a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a> and click on “Binding Assay” or “Functional Assay” on the menu bar (experimental details have been updated!).</div></div></div><div id="sec5_23_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> In Vivo Experiments</h3><div id="sec5_23_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Animals</h4><div class="NLM_p last">Male Sprague−Dawley rats (200−225 g) were purchased from Harlan. Animals were housed in a temperature and humidity controlled room with 12 h light/dark cycle. Food and water were accessible to animals freely throughout the duration of study. All testing occurred during the light component. All animal procedures were reviewed and approved by Wayne State University animal investigation committee consistent with AALAC guidelines.</div></div><div id="sec5_23_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Effect of Compound <b>10f</b> in the Rat Forced Swimming Test as a Measure of Its Antidepressant Property</h4><div class="NLM_p">The subjects were male Swiss Sprague−Dawley rats (Harlam Sprague−Dawley Inc., Indianapolis, IN, U.S.) weighing 200−225 g housed in cages for at least 1 week prior to testing. Animals were maintained in a temperature-controlled environment under a 12 h light/dark cycle. All subjects were naive and used only once.</div><div class="NLM_p">Rats were transported to the testing room at least for 1 h prior to testing for acclimatization and adaptation purposes. Experimental sessions were conducted between 9 a.m. to 2 p.m. daily. Animals were assigned randomly and were placed individually in a glass cylinder (24.5 cm × 35.5 cm) filled with water at room temperature to a depth of 22 cm. All the test sessions were recorded by a video camera. The water was changed in the beginning of each session, and the temperature was maintained constant at 24−25 °C. Rats were judged to be immobile if making minimum movement to barely keep afloat.</div><div class="NLM_p">The procedure consisted of a pretest and a test session separated by 24 h.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> During the pretest period, rats were placed in the swim chamber for 15 min. Followed by the initial swim exposure, rats were patted dry and were transferred to the individual cages. Drugs or vehicle was then administered (ip) 15 min after the initial swim exposure, and the rats were then transported to their home cages. On the following day the rats were brought back to the testing room at least 1 h before the beginning of test session. Rats were administered either drugs or vehicle 1 h before the swim test. Each rat underwent a 5 min swim session, which was videotaped and scored later. In the case of imipramine, the pretreatment time was 30 min.</div><div class="NLM_p last">All drugs were prepared freshly on the test days. Compound <b>10f</b> and imipramine were dissolved in 10% β-hydroxypropylcyclodextrin solution. All drugs and vehicles were administered ip. <b>10f</b> was administered at a dose of 10 mg/kg and the volume of injections was maintained at 2 mL/kg. Imipramine was administered at 15 mg/kg. All drugs and vehicles were administered 1 h prior to testing for FST. Imipramine was administered 30 min prior to testing. An individual, blinded to the treatment, scored the videotapes for immobility. Immobility scores were analyzed by one-way ANOVA test.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/jm200020a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Spectral data for <b>6b</b>, binding affinity of <b>10f</b>, and elemental analysis data for all final targets. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200020a/suppl_file/jm200020a_si_001.pdf">jm200020a_si_001.pdf (55.58 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200020a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aloke Dutta</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#88e9ecfdfcfce9c8ffe9f1e6eda6edecfd"><span class="__cf_email__" data-cfemail="8aebeefffefeebcafdebf3e4efa4efeeff">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bhaskar Gopishetty</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart Hazeldine</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soumava Santra</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Johnson</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gyan Modi</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Solav Ali</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Psychiatry and §Department of Pharmacology, New York University, New York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Zhen</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Psychiatry and §Department of Pharmacology, New York University, New York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maarten Reith</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Psychiatry and §Department of Pharmacology, New York University, New York, New York 10016, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work is supported by National Institute of Mental Health/The National Institutes of Health Grant MH084888 (A.D.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> Abbreviations Used</h2><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporters</p></td></tr><tr><td class="NLM_term">TUI</td><td class="NLM_def"><p class="first last">triple uptake inhibitor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure−activity relationship</p></td></tr><tr><td class="NLM_term">GBR 12909 dihydrochloride</td><td class="NLM_def"><p class="first last">(1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-[3-phenylpropyl]piperazine)</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">selective serotonin reuptake inhibitor</p></td></tr><tr><td class="NLM_term">DNRI</td><td class="NLM_def"><p class="first last">dopamine norepinephrine reuptake inhibitor</p></td></tr><tr><td class="NLM_term">NE</td><td class="NLM_def"><p class="first last">norepinephrine</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">serotonin</p></td></tr><tr><td class="NLM_term">FST</td><td class="NLM_def"><p class="first last">forced swim test</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kessler, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merikangas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span> </span><span class="NLM_article-title">The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=3095-3105&author=R.+C.+Kesslerauthor=P.+Berglundauthor=O.+Demlerauthor=R.+Jinauthor=D.+Koretzauthor=K.+R.+Merikangasauthor=A.+J.+Rushauthor=E.+E.+Waltersauthor=P.+S.+Wang&title=The+epidemiology+of+major+depressive+disorder%3A+results+from+the+National+Comorbidity+Survey+Replication+%28NCS-R%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DR.%2BC.%26aulast%3DBerglund%26aufirst%3DP.%26aulast%3DDemler%26aufirst%3DO.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DKoretz%26aufirst%3DD.%26aulast%3DMerikangas%26aufirst%3DK.%2BR.%26aulast%3DRush%26aufirst%3DA.%2BJ.%26aulast%3DWalters%26aufirst%3DE.%2BE.%26aulast%3DWang%26aufirst%3DP.%2BS.%26atitle%3DThe%2520epidemiology%2520of%2520major%2520depressive%2520disorder%253A%2520results%2520from%2520the%2520National%2520Comorbidity%2520Survey%2520Replication%2520%2528NCS-R%2529%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D3095%26epage%3D3105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lopez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. C.</span><span> </span><span class="NLM_article-title">The global burden of disease, 1990−2020</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1038%2F3218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=9809543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaK1cXntlantbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1241-1243&author=A.+D.+Lopezauthor=C.+C.+Murray&title=The+global+burden+of+disease%2C+1990%E2%88%922020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of disease, 1990-2020</span></div><div class="casAuthors">Lopez, Alan D.; Murray, Christopher C. J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1241-1243</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokLX9wB0X4L7Vg90H21EOLACvtfcHk0ljy6cnNP8RI2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlantbk%253D&md5=788b34ec83f13b3b659d42d6479087cf</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F3218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F3218%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DA.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BC.%26atitle%3DThe%2520global%2520burden%2520of%2520disease%252C%25201990%25E2%2588%25922020%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1241%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Dilsaver, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swann, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoaib, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K. J.</span><span> </span><span class="NLM_article-title">Suicidality in patients with pure and depressive mania</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1312</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1176%2Fajp.151.9.1312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=8067486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A280%3ADyaK2czks1Ghuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1994&pages=1312-1315&author=S.+C.+Dilsaverauthor=Y.+W.+Chenauthor=A.+C.+Swannauthor=A.+M.+Shoaibauthor=K.+J.+Krajewski&title=Suicidality+in+patients+with+pure+and+depressive+mania"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Suicidality in patients with pure and depressive mania</span></div><div class="casAuthors">Dilsaver S C; Chen Y W; Swann A C; Shoaib A M; Krajewski K J</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1312-5</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  A previous comprehensive literature review indicated that suicide accounted for 18.9% of the deaths of 9,389 individuals with manic-depressive illness.  The literature associates these deaths with the depressed phase of the disease.  This study was designed to determine the rate and severity of suicidality among patients with pure and depressive mania.  METHOD:  The patients were 93 persons who met the Research Diagnostic Criteria (RDC) for bipolar I disorder (N = 75) or schizoaffective disorder (N = 18).  All met the RDC for primary mania and the DSM-III-R criteria for bipolar disorder, manic or mixed.  Patients with depressive mania met the RDC for mania and major depressive disorder concurrently.  Severity of current suicidality was measured by using the Schedule for Affective Disorders and Schizophrenia suicide subscale.  Differences in the mean suicidality scores between any two groups were assessed with the Kruskal-Wallis test.  Relationships of age, gender, type of affective illness (bipolar I versus schizoaffective disorder), psychosis, race, and mania subtype to suicidality were assessed by using multivariate logistic regression analysis.  RESULTS:  One (2.0%) of the 49 patients with pure mania was suicidal.  In contrast, 24 (54.5%) of the 44 patients with depressive mania were suicidal.  This difference was highly significant.  Gender and psychosis were not related to suicidality.  African-Americans were less likely to be suicidal than Caucasians.  Subtype of mania had the strongest relationship to suicidality.  CONCLUSIONS:  A subgroup of manic patients are severely suicidal.  Presentation in the manic state is an indication for careful assessment of depressive symptoms and suicidality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTStpF6EVmx9669lAbTj9rGfW6udTcc2ebW39DjjFnFN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2czks1Ghuw%253D%253D&md5=8661ce0365cd77beeda92744beaf25bd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1176%2Fajp.151.9.1312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.151.9.1312%26sid%3Dliteratum%253Aachs%26aulast%3DDilsaver%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BW.%26aulast%3DSwann%26aufirst%3DA.%2BC.%26aulast%3DShoaib%26aufirst%3DA.%2BM.%26aulast%3DKrajewski%26aufirst%3DK.%2BJ.%26atitle%3DSuicidality%2520in%2520patients%2520with%2520pure%2520and%2520depressive%2520mania%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1994%26volume%3D151%26spage%3D1312%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Strakowski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, P. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. A.</span><span> </span><span class="NLM_article-title">Suicidality among patients with mixed and manic bipolar disorder</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1176%2Fajp.153.5.674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=8615413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A280%3ADyaK283gsFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1996&pages=674-676&author=S.+M.+Strakowskiauthor=S.+L.+McElroyauthor=P.+E.+Keckauthor=S.+A.+West&title=Suicidality+among+patients+with+mixed+and+manic+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Suicidality among patients with mixed and manic bipolar disorder</span></div><div class="casAuthors">Strakowski S M; McElroy S L; Keck P E Jr; West S A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-6</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Patients with mixed or manic bipolar disorder were studied to determine whether suicidality in mania is associated with increasing depression in general (i.e., a dimensional construct based on symptom severity) or with the presence of a mixed state per se (i.e., a categorical construct requiring the presence of a full depressive syndrome).  METHOD:  Diagnostic (categorical) assessments of 91 consecutively hospitalized patients with DSM-III-R mixed or manic bipolar disorder were made by using the Structural Clinical Interview for DSM-III-R.  Symptom (dimensional) assessments were made by using the Hamilton Depression Rating Scale, the Young Mania Rating Scale, and the Scale of the Assessment of Positive Symptoms.  Logistic regression models were employed to test the relative associations between suicidality and dimensional and categorical depression measures.  Receiver operating characteristics analysis was performed to identify a potential threshold depression rating that predicted suicidality.  RESULTS:  Suicidality was more common in mixed than manic bipolar disorder.  However, when adjusted for total depression scores, this association with affective state did not persist, but the statistical model significantly improved.  In the improved model, depressive symptom ratings were significantly associated with suicidality.  Hamilton depression scale ratings greater than 18 identified over 90% of the patients with suicidality, although there was also a high rate of false positives (32%).  CONCLUSIONS:  It is the severity of concurrent depressive symptoms in mania, rather than the presence of a depressive syndrome per se (i.e., mixed state), that is associated with suicidality in bipolar patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEOePgHccaLdenUz0lpNqnfW6udTcc2ebW39DjjFnFN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283gsFaktQ%253D%253D&md5=72c7ec9930cfe187f9f09fa4ac346263</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1176%2Fajp.153.5.674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.153.5.674%26sid%3Dliteratum%253Aachs%26aulast%3DStrakowski%26aufirst%3DS.%2BM.%26aulast%3DMcElroy%26aufirst%3DS.%2BL.%26aulast%3DKeck%26aufirst%3DP.%2BE.%26aulast%3DWest%26aufirst%3DS.%2BA.%26atitle%3DSuicidality%2520among%2520patients%2520with%2520mixed%2520and%2520manic%2520bipolar%2520disorder%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1996%26volume%3D153%26spage%3D674%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Psychopharmacology of affective disorders in the 21st century</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2FS0006-3223%2898%2900068-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=9787875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=517-525&author=C.+B.+Nemeroff&title=Psychopharmacology+of+affective+disorders+in+the+21st+century"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Psychopharmacology of affective disorders in the 21st century</span></div><div class="casAuthors">Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-525</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 24 refs. Over the past several years, remarkable advances have been made in the understanding of both the central nervous system and the pathophysiol. of the major psychiatric disorders, resulting in major breakthroughs in capacity to treat these devastating illnesses.  Since the seminal work of Ramon Y Cajal and Golgi at the turn of the century, new techniques such as fluorescence histochem. have evolved into immunohistochem. and more recently in situ hybridization.  These techniques have permitted, for the 1st time, the elucidation of chem. defined neural circuits.  Such advances in the mapping of neural systems and the visualization of monoaminergic and peptidergic neurons and their receptors in tissue sections have provided the tools for the burgeoning field of neurochem. pathol. of psychiatric disorders.  Data from such studies have served as the basis for the development of novel pharmacol. approaches to the treatment of affective and anxiety disorders, as well as schizophrenia.  This review focuses on 2 major neural systems implicated in the pathophysiol. of depression: serotonin and corticotropin-releasing factor (CRF).  Development of novel agents are described, including selective serotonin receptor agonists, combined selective serotonin receptor antagonists and serotonin reuptake inhibitors, CRF receptor antagonists, and the use of an antisense strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe1Gcb06NIcLVg90H21EOLACvtfcHk0lhdhNsg4jF_tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWksLw%253D&md5=4547cd80b997c1d00a5c20cd0536a329</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900068-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900068-7%26sid%3Dliteratum%253Aachs%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DPsychopharmacology%2520of%2520affective%2520disorders%2520in%2520the%252021st%2520century%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D517%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Iversen, L.</span><span> </span><span class="NLM_article-title">Neurotransmitter transporters: fruitful targets for CNS drug discovery</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1038%2Fsj.mp.4000728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=10889545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslGjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=357-362&author=L.+Iversen&title=Neurotransmitter+transporters%3A+fruitful+targets+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter transporters: fruitful targets for CNS drug discovery</span></div><div class="casAuthors">Iversen, L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-362</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 32 refs.  More than 20 members have been identified in the neurotransmitter transporter family.  These include the cell surface re-uptake mechanisms for monoamine and amino acid neurotransmitters and vesicular transporter mechanisms involved in neurotransmitter storage.  The norepinephrine and serotonin re-uptake transporters are key targets for antidepressant drugs.  Clin. effective antidepressants include those with selectivity for either NE or serotonin uptake, and compds. with mixed actions.  The dopamine transporter plays a key role in mediating the actions of cocaine and the amphetamines and in conferring selectivity on dopamine neurotoxins.  The only clin. used compd. to come so far from research on amino acid transporters is the antiepileptic drug tiagabine, a GABA uptake inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqYwFD8Vu3i7Vg90H21EOLACvtfcHk0lipGfqCbPWMOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslGjtLo%253D&md5=792cb672e96aa7b2cf541c27218924c7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4000728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4000728%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%26atitle%3DNeurotransmitter%2520transporters%253A%2520fruitful%2520targets%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DMol.%2520Psychiatry%26date%3D2000%26volume%3D5%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Schloss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. C.</span><span> </span><span class="NLM_article-title">The serotonin transporter: a primary target for antidepressant drugs</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1177%2F026988119801200201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=9694022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=115-121&author=P.+Schlossauthor=D.+C.+Williams&title=The+serotonin+transporter%3A+a+primary+target+for+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin transporter: a primary target for antidepressant drugs</span></div><div class="casAuthors">Schloss, Patrick; Williams, D. Clive</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-121</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">SAGE Publications</span>)
        </div><div class="casAbstract">A review with over 60 refs.  The serotoninergic system is known to modulate mood, emotion, sleep and appetite and thus is implicated in the control of numerous behavioral and physiol. functions.  Decreased serotoninergic neurotransmission has been proposed to play a key role in the etiol. of depression.  The concn. of synaptic serotonin is controlled directly by its reuptake into the pre-synaptic terminal and, thus, drugs blocking serotonin transport have been successfully used for the treatment of depression.  In addn. to tricyclic antidepressants (TCAs; e.g. imipramine) which also block noradrenaline reuptake, highly specific serotonin reuptake inhibitors (SSRIs) such as fluoxetine and paroxetine have been developed, which are increasingly prescribed for depressed patients.  The mode of action of these antidepressant drugs on their direct target, the serotonin transport protein, and possible regulatory mechanisms with respect to long-term alleviation of depression, although having been investigated both neurobiol. and clin. over the last years, are not yet understood.  The cloning of the cDNA encoding the serotonin transporter has allowed a more precise characterization of this protein at the mol. level.  This will show how antidepressants act at this target, thereby affecting the biochem., pharmacol. and electrophysiol. properties of the serotoninergic system and give an introduction of how they might exert their therapeutic effect.  This review gives an overview of the recent developments in this field, discusses mechanisms of antidepressant action on this target, and also possible interactions with other components of serotoninergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVjZAiA8RSW7Vg90H21EOLACvtfcHk0lipGfqCbPWMOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGmt7c%253D&md5=cc605d7200cca439749f26e2bb284091</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1177%2F026988119801200201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988119801200201%26sid%3Dliteratum%253Aachs%26aulast%3DSchloss%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26atitle%3DThe%2520serotonin%2520transporter%253A%2520a%2520primary%2520target%2520for%2520antidepressant%2520drugs%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D1998%26volume%3D12%26spage%3D115%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amsterdam, J. D.</span><span> </span><span class="NLM_article-title">Treatment-resistant depression: definition and treatment approaches</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><div class="note"><p class="first last">; discussion 48−50</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=2112132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A280%3ADyaK3c3ntVaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1990&pages=39-47&issue=Suppl.&author=A.+A.+Nierenbergauthor=J.+D.+Amsterdam&title=Treatment-resistant+depression%3A+definition+and+treatment+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment-resistant depression: definition and treatment approaches</span></div><div class="casAuthors">Nierenberg A A; Amsterdam J D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical psychiatry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">51 Suppl</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-47; discussion 48-50</span>
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    </div><div class="casAbstract">Little systematic attention has been directed toward the subject of treatment-resistant depression.  Although these patients constitute a distinct minority, their treatment consumes a major portion of the clinician's time.  Thus, the authors address the problems of defining and treating the estimated 750,000 patients with treatment-resistant depression.  Several major factors concerning treatment-resistant depression appear evident: (1) although there is an emerging consensus of what constitutes "adequate" treatment, the majority of patients receive suboptimal drug regimens; (2) misdiagnosis of depression subtypes can lead to suboptimal treatment and "pseudo-resistance" to drug therapy; (3) treatment strategies for resistant depression should use systematic algorithms to avoid confusion and limit "therapeutic nihilism" in the patient and physician; and (4) the patient's risk/benefit ratio for each successive treatment application must be considered with the potential benefit weighed against the increasing risk of illness morbidity and likelihood of adverse events and/or suicide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRl0pdntjAgiub6AVA-44PTfW6udTcc2ebFAUi1Ks6_57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ntVaktA%253D%253D&md5=9833159b4ea0d28c0bf54839271554b1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DAmsterdam%26aufirst%3DJ.%2BD.%26atitle%3DTreatment-resistant%2520depression%253A%2520definition%2520and%2520treatment%2520approaches%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1990%26volume%3D51%26issue%3DSuppl%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quitkin, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span> </span><span class="NLM_article-title">Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1012-1018&author=A.+A.+Nierenbergauthor=F.+M.+Quitkinauthor=C.+Kremerauthor=M.+B.+Kellerauthor=M.+E.+Thase&title=Placebo-controlled+continuation+treatment+with+mirtazapine%3A+acute+pattern+of+response+predicts+relapse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DQuitkin%26aufirst%3DF.%2BM.%26aulast%3DKremer%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DM.%2BB.%26aulast%3DThase%26aufirst%3DM.%2BE.%26atitle%3DPlacebo-controlled%2520continuation%2520treatment%2520with%2520mirtazapine%253A%2520acute%2520pattern%2520of%2520response%2520predicts%2520relapse%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1012%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">D’Aquila, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessa, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, G.</span><span> </span><span class="NLM_article-title">The role of dopamine in the mechanism of action of antidepressant drugs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2FS0014-2999%2800%2900566-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=11033341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Sitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=365-373&author=P.+S.+D%E2%80%99Aquilaauthor=M.+Colluauthor=G.+L.+Gessaauthor=G.+Serra&title=The+role+of+dopamine+in+the+mechanism+of+action+of+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of dopamine in the mechanism of action of antidepressant drugs</span></div><div class="casAuthors">D'Aquila, P. S.; Collu, M.; Gessa, G. L.; Serra, G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">365-373</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with >100 refs.  The present paper reviews evidence on the effect of antidepressant treatments on dopamine transmission.  Chronic treatment with antidepressant drugs potentiates the behavioral stimulant responses elicited by the stimulation of dopamine receptors, including reward-related behaviors.  Moreover, antidepressants affect dopamine release in several brain areas.  The reviewed literature is discussed in terms of the possible mechanisms underlying antidepressant-induced supersensitivity to dopamine-mediated behavioral responses, and of the possible implications for the therapeutic effect of these drugs.  It is concluded that the potentiation of dopaminergic neurotransmission induced by chronic antidepressant treatments might contribute to their therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRApOdl32jcbVg90H21EOLACvtfcHk0lipGfqCbPWMOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Sitbk%253D&md5=8ad7e0a9f61e0f36c2860e7be53ecb11</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900566-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900566-5%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Aquila%26aufirst%3DP.%2BS.%26aulast%3DCollu%26aufirst%3DM.%26aulast%3DGessa%26aufirst%3DG.%2BL.%26aulast%3DSerra%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520dopamine%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520antidepressant%2520drugs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D405%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Papakostas, G. I.</span><span> </span><span class="NLM_article-title">Dopaminergic-based pharmacotherapies for depression</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.euroneuro.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=16413172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=391-402&author=G.+I.+Papakostas&title=Dopaminergic-based+pharmacotherapies+for+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dopaminergic-based pharmacotherapies for depression</span></div><div class="casAuthors">Papakostas, George I.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">391-402</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The serendipitous discovery of the precursors of two of the major contemporary antidepressant families during the late 1950s, iproniazid for the monoamine oxidase inhibitors (MAOIs) and imipramine for the tricyclic antidepressants (TCAs), has guided the subsequent development of antidepressant compds. with predominantly serotonergic, noradrenergic or combined serotonergic and noradrenergic activity.  Unfortunately, however, many depressed patients continue to remain symptomatic despite adequate treatment with pharmacol. agents currently available.  When one reviews the list of pharmacol. agents currently approved for the treatment of Major Depressive Disorder (MDD), it is apparent that relatively few treatments with dopaminergic activity have been developed to date.  Therefore, developing effective antidepressant treatments with pro-dopaminergic properties which also possess a relatively wide safety margin may further improve the std. of care for depression.  In the present article we will briefly review studies focusing on the role of dopamine in depression followed by a comprehensive review of pharmacotherapies for depression with pro-dopaminergic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSaNt7Y60YLVg90H21EOLACvtfcHk0ljFExozFyEGlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D&md5=d8c07a50f819444bf5d432b99f1d6af4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPapakostas%26aufirst%3DG.%2BI.%26atitle%3DDopaminergic-based%2520pharmacotherapies%2520for%2520depression%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D16%26spage%3D391%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Clayton, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnock, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornstein, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon-Keller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarvey, E. L.</span><span> </span><span class="NLM_article-title">A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.4088%2FJCP.v65n0110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=14744170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs12qsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=62-67&author=A.+H.+Claytonauthor=J.+K.+Warnockauthor=S.+G.+Kornsteinauthor=R.+Pinkertonauthor=A.+Sheldon-Kellerauthor=E.+L.+McGarvey&title=A+placebo-controlled+trial+of+bupropion+SR+as+an+antidote+for+selective+serotonin+reuptake+inhibitor-induced+sexual+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction</span></div><div class="casAuthors">Clayton, Anita H.; Warnock, Julia K.; Kornstein, Susan G.; Pinkerton, Relana; Sheldon-Keller, Adrienne; McGarvey, Elizabeth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-67</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">Objective: This study reports the results of a placebo-controlled, double-blind comparison of bupropion sustained release (SR) as an antidote for sexual dysfunction vs. placebo in 42 patients with selective serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction.  Exploratory analyses of the assocn. of testosterone and sexual functioning in women in the study were also performed.  Method: Patients with DSM-IV major depression who experienced a therapeutic response to any SSRI and were experiencing medication-induced global or phase-specific sexual dysfunction, as measured by the Changes in Sexual Functioning Questionnaire (CSFQ), were randomly assigned to receive either bupropion SR 150 mg b.i.d. or placebo for 4 wk in addn. to the SSRI.  Total testosterone levels were assessed at baseline and week 4.  Results: The difference in global sexual functioning, based on the total CSFQ score, was not statistically significant between the 2 groups at week 4, nor were differences in orgasm, desire/interest as measured by sexual thoughts, or self-reported arousal.  There was a statistically significant difference between the 2 groups at week 4 in desire as measured by self-report feelings of desire and frequency of sexual activity.  Desire/frequency showed a significantly greater improvement among those patients receiving bupropion SR compared with placebo (Wilk's F = 5.47, df = 1, p = .024).  Frequency was significantly correlated to total testosterone level at baseline (r = 0.36, p = .027) and at week 4 (r = 0.41, p =. 025).  Conclusions: Bupropion SR, as an effective antidote to SSRI-induced sexual dysfunction, produced an increase in desire to engage in sexual activity and frequency of engaging in sexual activity compared with placebo.  A larger study is needed to further investigate this finding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjsACDZkqu-rVg90H21EOLACvtfcHk0ljFExozFyEGlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs12qsb4%253D&md5=42a907c58ae9f9e0360f2dab936cabb6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4088%2FJCP.v65n0110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v65n0110%26sid%3Dliteratum%253Aachs%26aulast%3DClayton%26aufirst%3DA.%2BH.%26aulast%3DWarnock%26aufirst%3DJ.%2BK.%26aulast%3DKornstein%26aufirst%3DS.%2BG.%26aulast%3DPinkerton%26aufirst%3DR.%26aulast%3DSheldon-Keller%26aufirst%3DA.%26aulast%3DMcGarvey%26aufirst%3DE.%2BL.%26atitle%3DA%2520placebo-controlled%2520trial%2520of%2520bupropion%2520SR%2520as%2520an%2520antidote%2520for%2520selective%2520serotonin%2520reuptake%2520inhibitor-induced%2520sexual%2520dysfunction%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2004%26volume%3D65%26spage%3D62%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Damsa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi-Demicheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidailhet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyenburg, S.</span><span> </span><span class="NLM_article-title">“Dopamine-dependent” side effects of selective serotonin reuptake inhibitors: a clinical review</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1064</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.4088%2FJCP.v65n0806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=15323590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFKhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=1064-1068&author=C.+Damsaauthor=A.+Bumbauthor=F.+Bianchi-Demicheliauthor=P.+Vidailhetauthor=R.+Sterckauthor=A.+Andreoliauthor=S.+Beyenburg&title=%E2%80%9CDopamine-dependent%E2%80%9D+side+effects+of+selective+serotonin+reuptake+inhibitors%3A+a+clinical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review</span></div><div class="casAuthors">Damsa, Cristian; Bumb, Anja; Bianchi-Demicheli, Francesco; Vidailhet, Pierre; Sterck, Robert; Andreoli, Antonio; Beyenburg, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1064-1068</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Neurophysiol. findings indicate an inhibition of dopaminergic neurotransmission by selective serotonin reuptake inhibitors (SSRIs).  This article highlights the relationships between changes in dopaminergic neurotransmission induced by SSRIs and the occurrence of certain side effects such as hyperprolactinemia, extrapyramidal symptoms, sexual and cognitive dysfunction, galactorrhea, mammary hypertrophy, and, more rarely, gynecomastia.  A systematic search of the literature in English, French, and German from 1980 to 2004 was performed in MEDLINE, EMBASE, and the Cochrane Library using the keywords SSRI, dopamine, serotonin, side effects, antidepressants, citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine, and nefazodone.  Refs. cited in all trials were searched iteratively to identify missing studies.  All studies concerning inhibition of dopaminergic neurotransmission by SSRIs and SSRI-related side effects were considered.  We retained 62 significant articles debating the subject.  We critically reviewed the studies, depending on the methodologies (case reports, clin. reports, randomized studies), and assessed the pertinence of "dopamine-dependent" SSRI-related side effects.  The analytic review of these articles suggests that some specific SSRI-related side effects be classified as dopamine-dependent.  At a clin. level, it could be useful to underline dopamine-dependent characteristics of some SSRI-related side effects.  This approach would allow clinicians the opportunity to search other dopamine-dependent side effects systematically.  At a pharmacol. level, this approach could stimulate the development of mols. with a "corrective" function on dopamine-dependent side effects of SSRIs by facilitating dopaminergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblfNLoRf397Vg90H21EOLACvtfcHk0ljFExozFyEGlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFKhtrY%253D&md5=279e2ef460a4a62e5ed40cffc8b111fc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4088%2FJCP.v65n0806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v65n0806%26sid%3Dliteratum%253Aachs%26aulast%3DDamsa%26aufirst%3DC.%26aulast%3DBumb%26aufirst%3DA.%26aulast%3DBianchi-Demicheli%26aufirst%3DF.%26aulast%3DVidailhet%26aufirst%3DP.%26aulast%3DSterck%26aufirst%3DR.%26aulast%3DAndreoli%26aufirst%3DA.%26aulast%3DBeyenburg%26aufirst%3DS.%26atitle%3D%25E2%2580%259CDopamine-dependent%25E2%2580%259D%2520side%2520effects%2520of%2520selective%2520serotonin%2520reuptake%2520inhibitors%253A%2520a%2520clinical%2520review%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2004%26volume%3D65%26spage%3D1064%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2FS0014-2999%2803%2901310-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=12586204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2003&pages=99-104&author=P.+Skolnickauthor=P.+Popikauthor=A.+Janowskyauthor=B.+Beerauthor=A.+S.+Lippa&title=Antidepressant-like+actions+of+DOV+21%2C947%3A+a+%E2%80%9Ctriple%E2%80%9D+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor</span></div><div class="casAuthors">Skolnick, Phil; Popik, Piotr; Janowsky, Aaron; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">99-104</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">DOV 21,947 [(+)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride] inhibits the reuptake of [3H]serotonin, [3H]norepinephrine, and [3H]dopamine in human embryonic kidney (HEK) 293 cells expressing the corresponding human recombinant transporters (IC50 values of 12, 23, and 96 nM, resp.).  This compd. also inhibits [125I]RTI 55 (3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester) binding to the corresponding transporter proteins in membranes prepd. from these cells (Ki values of 99, 262, and 213 nM, resp.).  DOV 21,947 reduces the duration of immobility in the forced swim test (using rats) with an oral min. ED of 5 mg/kg.  This antidepressant-like effect manifests in the absence of significant increases in motor activity at doses of up to 20 mg/kg.  DOV 21,947 also produces a dose-dependent redn. in immobility in the tail suspension test, with a min. effective oral dose of 5 mg/kg.  The ability of DOV 21,947 to inhibit the reuptake of three biogenic amines closely linked to the etiol. of depression may result in a therapeutic profile different from antidepressants that inhibit the reuptake of serotonin and/or norepinephrine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Q0j1ranmerVg90H21EOLACvtfcHk0lh83ZWv3CRYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D&md5=6d48dc293c8237d42932da3effa40b8a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901310-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901310-4%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DAntidepressant-like%2520actions%2520of%2520DOV%252021%252C947%253A%2520a%2520%25E2%2580%259Ctriple%25E2%2580%259D%2520reuptake%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D461%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Shaw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">555</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.ejphar.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=17109850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFKhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2007&pages=30-36&author=A.+M.+Shawauthor=M.+Boulesauthor=Y.+Zhangauthor=K.+Williamsauthor=J.+Robinsonauthor=P.+R.+Carlierauthor=E.+Richelson&title=Antidepressant-like+effects+of+novel+triple+reuptake+inhibitors%2C+PRC025+and+PRC050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050</span></div><div class="casAuthors">Shaw, Amanda M.; Boules, Mona; Zhang, Yiqun; Williams, Katrina; Robinson, Jessica; Carlier, Paul R.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-36</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Most currently prescribed antidepressants act by selectively increasing the synaptic availability of serotonin or norepinephrine, or through action on both serotonin and norepinephrine.  However, most therapies require several weeks of treatment before improvement of symptoms is obsd. and not all patients respond to antidepressant treatment.  One strategy that has emerged in new antidepressant development is the use of triple reuptake inhibitors, which inhibit reuptake of serotonin, norepinephrine, and dopamine.  These compds. have been hypothesized to have a more rapid onset of activity and better efficacy over single or dual reuptake inhibitor antidepressants in part due to the addn. of the dopamine component.  The authors have developed novel compds. that are analogs of venlafaxine, of which two, racemic PRC025 ((2SR, 3RS)-N,N-dimethyl-3-cyclohexyl-3-hydroxy-2-(2'-naphthyl)propylamine) and PRC050 ((2RS,3RS)-N-methyl-3-hydroxy-2-(2'-naphthyl)-3-phenylpropylamine), are highly potent at human serotonin, norepinephrine, and dopamine transporters and inhibit the reuptake of serotonin, norepinephrine, and dopamine into rat brain synaptosomes.  These compds. were tested in animal models used to evaluate potential antidepressants: the forced swim test in rats and the tail suspension test in mice.  In the forced swim test, both PRC025 and PRC050 reduced the time spent immobile and increased the time spent swimming, comparable to the effects seen with imipramine, a tricyclic antidepressant.  In addn., both PRC025 and PRC050 were effective in reducing the time spent immobile in the tail suspension test, again with effects comparable to imipramine.  Therefore it appears that our compds. may possess antidepressant activity and represent a new class of triple reuptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNFgOGIhoBvLVg90H21EOLACvtfcHk0lh83ZWv3CRYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFKhtw%253D%253D&md5=27ba548eac72b50abedf771e55174fab</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BM.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAntidepressant-like%2520effects%2520of%2520novel%2520triple%2520reuptake%2520inhibitors%252C%2520PRC025%2520and%2520PRC050%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D555%26spage%3D30%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basile, A. S.</span><span> </span><span class="NLM_article-title">Triple reuptake inhibitors (“broad spectrum” antidepressants)</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.2174%2F187152707780363285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=17430151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltValtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=141-149&author=P.+Skolnickauthor=A.+S.+Basile&title=Triple+reuptake+inhibitors+%28%E2%80%9Cbroad+spectrum%E2%80%9D+antidepressants%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Triple reuptake inhibitors ("broad spectrum" antidepressants)</span></div><div class="casAuthors">Skolnick, Phil; Basile, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-149</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The majority of antidepressants in current use inhibit the uptake of serotonin and/or norepinephrine.  Drugs inhibiting the uptake of serotonin, norepinephrine and dopamine (triple reuptake inhibitors) may offer therapeutic advantages compared to single and/or dual reuptake inhibitors.  This review provides a rationale for developing this class of compd. and describes the results of preclin. and clin. studies with a family of triple reuptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnlyNGAigKoLVg90H21EOLACvtfcHk0lh83ZWv3CRYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltValtbo%253D&md5=f5bde2286f4f0cce3f911a47645a5c88</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F187152707780363285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707780363285%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DBasile%26aufirst%3DA.%2BS.%26atitle%3DTriple%2520reuptake%2520inhibitors%2520%2528%25E2%2580%259Cbroad%2520spectrum%25E2%2580%259D%2520antidepressants%2529%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D141%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briody, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1<i>S</i>,2<i>S</i>)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1124%2Fjpet.108.143610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=18689611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=573-583&author=Y.+Liangauthor=A.+M.+Shawauthor=M.+Boulesauthor=S.+Briodyauthor=J.+Robinsonauthor=A.+Oliverosauthor=E.+Blazarauthor=K.+Williamsauthor=Y.+Zhangauthor=P.+R.+Carlierauthor=E.+Richelson&title=Antidepressant-like+pharmacological+profile+of+a+novel+triple+reuptake+inhibitor%2C+%281S%2C2S%29-3-%28methylamino%29-2-%28naphthalen-2-yl%29-1-phenylpropan-1-ol+%28PRC200-SS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span></div><div class="casAuthors">Liang, Yanqi; Shaw, Amanda M.; Boules, Mona; Briody, Siobhan; Robinson, Jessica; Oliveros, Alfredo; Blazar, Eric; Williams, Katrina; Zhang, Yiqun; Carlier, Paul R.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-583</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Due to the putative involvement of dopaminergic circuits in depression, triple reuptake inhibitors are being developed as a new class of antidepressant, which is hypothesized to produce a more rapid onset and better efficacy than current antidepressants selective for serotonin or norepinephrine neurotransmission.  (1S,2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC 200SS), a new triple reuptake inhibitor, potently bound to the human serotonin, norepinephrine, and dopamine transporters with Kd values of 2.3, 0.63, and 18 nM, resp.  Inhibition of serotonin, norepinephrine, and dopamine uptake by PRC 200SS was also shown in cells expressing the corresponding transporter (Ki values of 2.1, 1.5, and 61 nM, resp.).  In vivo, PRC 200SS dose-dependently decreased immobility in the forced-swim test in rats and in the tail-suspension test in mice, models predictive of antidepressant activity, with effects comparable with imipramine.  These results in the behavioral models did not seem to result from the stimulation of locomotor activity.  Consistent with the in vitro data and behavioral effects, peripheral administration of PRC 200SS (5 and 10 mg/kg i.p.) significantly increased extracellular levels of serotonin and norepinephrine in the medial prefrontal cortex, and of serotonin and dopamine in the core of nucleus accumbens, with redn. of levels of 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid compared with levels for saline control.  Furthermore, PRC 200SS self-administration, which was used as a marker of abuse liability, was not obsd. with rats.  Therefore, it seems that PRC 200SS may represent a novel triple reuptake inhibitor and possess antidepressant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjq1Ko19NBbVg90H21EOLACvtfcHk0lh83ZWv3CRYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ&md5=1cfb6ece94bf5fa1187219d03f676d09</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143610%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DA.%2BM.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DBriody%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DOliveros%26aufirst%3DA.%26aulast%3DBlazar%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAntidepressant-like%2520pharmacological%2520profile%2520of%2520a%2520novel%2520triple%2520reuptake%2520inhibitor%252C%2520%25281S%252C2S%2529-3-%2528methylamino%2529-2-%2528naphthalen-2-yl%2529-1-phenylpropan-1-ol%2520%2528PRC200-SS%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D573%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czobor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A.</span><span> </span><span class="NLM_article-title">Preclinical and clinical pharmacology of DOV 216,303, a “triple” reuptake inhibitor</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=123-134&author=P.+Skolnickauthor=P.+Krieterauthor=J.+Tizzanoauthor=A.+Basileauthor=P.+Popikauthor=P.+Czoborauthor=A.+Lippa&title=Preclinical+and+clinical+pharmacology+of+DOV+216%2C303%2C+a+%E2%80%9Ctriple%E2%80%9D+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DKrieter%26aufirst%3DP.%26aulast%3DTizzano%26aufirst%3DJ.%26aulast%3DBasile%26aufirst%3DA.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DCzobor%26aufirst%3DP.%26aulast%3DLippa%26aufirst%3DA.%26atitle%3DPreclinical%2520and%2520clinical%2520pharmacology%2520of%2520DOV%2520216%252C303%252C%2520a%2520%25E2%2580%259Ctriple%25E2%2580%259D%2520reuptake%2520inhibitor%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of novel 2,5-disubstituted cis- and trans-piperidine derivatives exhibiting differential activity for the dopamine transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2337</span><span class="NLM_x">–</span> <span class="NLM_lpage">2340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2337-2340&author=A.+K.+Duttaauthor=M.+C.+Davisauthor=M.+E.+Reith&title=Rational+design+and+synthesis+of+novel+2%2C5-disubstituted+cis-+and+trans-piperidine+derivatives+exhibiting+differential+activity+for+the+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520novel%25202%252C5-disubstituted%2520cis-%2520and%2520trans-piperidine%2520derivatives%2520exhibiting%2520differential%2520activity%2520for%2520the%2520dopamine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2337%26epage%3D2340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Expansion of structure−activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the <i>N</i>-benzyl moiety and behavioral pharmacology of selected molecules</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010316x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=654-662&author=A.+K.+Duttaauthor=M.+C.+Davisauthor=X.+S.+Feiauthor=P.+M.+Beardsleyauthor=C.+D.+Cookauthor=M.+E.+Reith&title=Expansion+of+structure%E2%88%92activity+studies+of+piperidine+analogues+of+1-%5B2-%28diphenylmethoxy%29ethyl%5D-4-%283-phenylpropyl%29piperazine+%28GBR+12935%29+compounds+by+altering+substitutions+in+the+N-benzyl+moiety+and+behavioral+pharmacology+of+selected+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm010316x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010316x%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DFei%26aufirst%3DX.%2BS.%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26aulast%3DCook%26aufirst%3DC.%2BD.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DExpansion%2520of%2520structure%25E2%2588%2592activity%2520studies%2520of%2520piperidine%2520analogues%2520of%25201-%255B2-%2528diphenylmethoxy%2529ethyl%255D-4-%25283-phenylpropyl%2529piperazine%2520%2528GBR%252012935%2529%2520compounds%2520by%2520altering%2520substitutions%2520in%2520the%2520N-benzyl%2520moiety%2520and%2520behavioral%2520pharmacology%2520of%2520selected%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D654%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ghorai, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1220</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020275k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1220-1228&author=S.+K.+Ghoraiauthor=C.+Cookauthor=M.+Davisauthor=S.+K.+Venkataramanauthor=C.+Georgeauthor=P.+M.+Beardsleyauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=High+affinity+hydroxypiperidine+analogues+of+4-%282-benzhydryloxyethyl%29-1-%284-fluorobenzyl%29piperidine+for+the+dopamine+transporter%3A+stereospecific+interactions+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm020275k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020275k%26sid%3Dliteratum%253Aachs%26aulast%3DGhorai%26aufirst%3DS.%2BK.%26aulast%3DCook%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DVenkataraman%26aufirst%3DS.%2BK.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DHigh%2520affinity%2520hydroxypiperidine%2520analogues%2520of%25204-%25282-benzhydryloxyethyl%2529-1-%25284-fluorobenzyl%2529piperidine%2520for%2520the%2520dopamine%2520transporter%253A%2520stereospecific%2520interactions%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1220%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolhatkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Dopamine transporter as target for drug development of cocaine dependence medications</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">479</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.ejphar.2003.08.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=14612141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=479&publication_year=2003&pages=93-106&author=A.+K.+Duttaauthor=S.+Zhangauthor=R.+Kolhatkarauthor=M.+E.+Reith&title=Dopamine+transporter+as+target+for+drug+development+of+cocaine+dependence+medications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transporter as target for drug development of cocaine dependence medications</span></div><div class="casAuthors">Dutta, Aloke K.; Zhang, Shijun; Kolhatkar, Rohit; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">479</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">93-106</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Because much evidence implicates the dopamine transporter in the reinforcing effects of cocaine, development of potential medications for cocaine dependence has included the dopamine transporter as a target.  The present overview covers progress in the drug development area regarding several classes of dopamine uptake inhibitors, with an emphasis on structure-activity relationships that enhance potency and selectivity at transporters for dopamine compared with those for serotonin or norepinephrine.  The following categories of compds. are covered: tropane, benztropine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR), methylphenidate, mazindol, and phencyclidine analogs.  Activity at transporters as well as on behavior is highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUvNoDOWGKRbVg90H21EOLACvtfcHk0lghvXvBkcBMGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGntLg%253D&md5=7a1ad0ab734b33159dcdde6c16785129</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2003.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2003.08.060%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKolhatkar%26aufirst%3DR.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DDopamine%2520transporter%2520as%2520target%2520for%2520drug%2520development%2520of%2520cocaine%2520dependence%2520medications%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D479%26spage%3D93%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1591-1595&author=S.+Zhangauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Design%2C+synthesis%2C+and+activity+of+novel+cis-+and+trans-3%2C6-disubstituted+pyran+biomimetics+of+3%2C6-disubstituted+piperidine+as+potential+ligands+for+the+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520activity%2520of%2520novel%2520cis-%2520and%2520trans-3%252C6-disubstituted%2520pyran%2520biomimetics%2520of%25203%252C6-disubstituted%2520piperidine%2520as%2520potential%2520ligands%2520for%2520the%2520dopamine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1591%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kolhatkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghorai, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structurally constrained analogues of <i>cis</i>-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5101</span><span class="NLM_x">–</span> <span class="NLM_lpage">5113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049796t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5101-5113&author=R.+Kolhatkarauthor=C.+D.+Cookauthor=S.+K.+Ghoraiauthor=J.+Deschampsauthor=P.+M.+Beardsleyauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structurally+constrained+analogues+of+cis-%286-benzhydrylpiperidin-3-yl%29benzylamine+with+elucidation+of+bioactive+conformation%3A+discovery+of+1%2C4-diazabicyclo%5B3.3.1%5Dnonane+derivatives+and+evaluation+of+their+biological+properties+for+the+monoamine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm049796t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049796t%26sid%3Dliteratum%253Aachs%26aulast%3DKolhatkar%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DC.%2BD.%26aulast%3DGhorai%26aufirst%3DS.%2BK.%26aulast%3DDeschamps%26aufirst%3DJ.%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structurally%2520constrained%2520analogues%2520of%2520cis-%25286-benzhydrylpiperidin-3-yl%2529benzylamine%2520with%2520elucidation%2520of%2520bioactive%2520conformation%253A%2520discovery%2520of%25201%252C4-diazabicyclo%255B3.3.1%255Dnonane%2520derivatives%2520and%2520evaluation%2520of%2520their%2520biological%2520properties%2520for%2520the%2520monoamine%2520transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5101%26epage%3D5113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of <i>cis</i>-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6301</span><span class="NLM_x">–</span> <span class="NLM_lpage">6315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=6301-6315&author=S.+Zhangauthor=J.+Zhenauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Structural+requirements+for+2%2C4-+and+3%2C6-disubstituted+pyran+biomimetics+of+cis-%286-benzhydryl-piperidin-3-yl%29-benzylamine+compounds+to+interact+with+monoamine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DStructural%2520requirements%2520for%25202%252C4-%2520and%25203%252C6-disubstituted%2520pyran%2520biomimetics%2520of%2520cis-%25286-benzhydryl-piperidin-3-yl%2529-benzylamine%2520compounds%2520to%2520interact%2520with%2520monoamine%2520transporters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D6301%26epage%3D6315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Discovery of novel trisubstituted asymmetric derivatives of (2<i>S</i>,4<i>R</i>,5<i>R</i>)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4962</span><span class="NLM_x">–</span> <span class="NLM_lpage">4971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049021k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4962-4971&author=S.+Zhangauthor=J.+Zhenauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Discovery+of+novel+trisubstituted+asymmetric+derivatives+of+%282S%2C4R%2C5R%29-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol%2C+exhibiting+high+affinity+for+serotonin+and+norepinephrine+transporters+in+a+stereospecific+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm049021k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049021k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDiscovery%2520of%2520novel%2520trisubstituted%2520asymmetric%2520derivatives%2520of%2520%25282S%252C4R%252C5R%2529-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol%252C%2520exhibiting%2520high%2520affinity%2520for%2520serotonin%2520and%2520norepinephrine%2520transporters%2520in%2520a%2520stereospecific%2520manner%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4962%26epage%3D4971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeldine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structural exploration of trisubstituted asymmetric pyran derivatives (2<i>S</i>,4<i>R</i>,5<i>R</i>)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3<i>S</i>,6<i>S</i>) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4239</span><span class="NLM_x">–</span> <span class="NLM_lpage">4247</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601699" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4239-4247&author=S.+Zhangauthor=F.+Fernandezauthor=S.+Hazeldineauthor=J.+Deschampsauthor=J.+Zhenauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structural+exploration+of+trisubstituted+asymmetric+pyran+derivatives+%282S%2C4R%2C5R%29-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol+and+their+corresponding+disubstituted+%283S%2C6S%29+pyran+derivatives%3A+a+proposed+pharmacophore+model+for+high-affinity+interaction+with+the+dopamine%2C+serotonin%2C+and+norepinephrine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0601699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601699%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DHazeldine%26aufirst%3DS.%26aulast%3DDeschamps%26aufirst%3DJ.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structural%2520exploration%2520of%2520trisubstituted%2520asymmetric%2520pyran%2520derivatives%2520%25282S%252C4R%252C5R%2529-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol%2520and%2520their%2520corresponding%2520disubstituted%2520%25283S%252C6S%2529%2520pyran%2520derivatives%253A%2520a%2520proposed%2520pharmacophore%2520model%2520for%2520high-affinity%2520interaction%2520with%2520the%2520dopamine%252C%2520serotonin%252C%2520and%2520norepinephrine%2520transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4239%26epage%3D4247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">589</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.ejphar.2008.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=18561912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVCmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=589&publication_year=2008&pages=73-79&author=A.+K.+Duttaauthor=B.+Ghoshauthor=S.+Biswasauthor=M.+E.+Reith&title=D-161%2C+a+novel+pyran-based+triple+monoamine+transporter+blocker%3A+behavioral+pharmacological+evidence+for+antidepressant-like+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">D-161, a novel pyran-based triple monoamine transporter blocker: Behavioral pharmacological evidence for antidepressant-like action</span></div><div class="casAuthors">Dutta, Aloke K.; Ghosh, Balaram; Biswas, Swati; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">589</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">73-79</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Deficiency in dopaminergic activity has been linked to a depressed state in pharmacol. and clin. studies.  Current pharmacol. treatment for depression primarily involves modulation of serotonergic and noradrenergic systems but not dopaminergic neurotransmission.  Available pharmacotherapy for depression has a no. of drawbacks as a significant no. of people are either refractory or develop tolerance to the antidepressant agents resulting in relapse.  Furthermore, the slow onset of action of current therapies often poses a challenge for effective treatment.  In our effort to develop novel mols. impacting all three above mentioned monoamine systems, we discovered structurally unique pyran derivs. with various profiles in inhibiting monoamine transporters.  One of our lead mols., D-161 exhibited triple monoamine transporter inhibitory activity with the highest affinity for norepinephrine transporter (NET) followed by its affinity for serotonin transporter (SERT) and dopamine transporter (DAT).  D-161 exhibited potent activity in reducing immobility significantly in the rat forced swim test as well as in the mouse tail suspension test.  Moreover, results from locomotor activity tests indicated that the redn. of immobility by D-161 was not due to motor activation as no significant motor activation was obsd. when the rats were subjected to the same doses of drug under the same conditions as in the forced swim test.  These results suggest that the novel asym. pyran deriv. D-161 with unique mol. structure exhibiting triple monoamine transporter inhibitory activity could possess potent antidepressant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqClWsN6M4N3bVg90H21EOLACvtfcHk0liPmQVy8PY5hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVCmtL0%253D&md5=d1a459f96d53829ef5f484500ad524a8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DD-161%252C%2520a%2520novel%2520pyran-based%2520triple%2520monoamine%2520transporter%2520blocker%253A%2520behavioral%2520pharmacological%2520evidence%2520for%2520antidepressant-like%2520action%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D589%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsin, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5042</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990291q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5029-5042&author=D.+B.+Lewisauthor=D.+Mateckaauthor=Y.+Zhangauthor=L.+W.+Hsinauthor=C.+M.+Derschauthor=D.+Staffordauthor=J.+R.+Glowaauthor=R.+B.+Rothmanauthor=K.+C.+Rice&title=Oxygenated+analogues+of+1-%5B2-%28diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5Bbis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+potential+extended-action+cocaine-abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm990291q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990291q%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DOxygenated%2520analogues%2520of%25201-%255B2-%2528diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255Bbis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520potential%2520extended-action%2520cocaine-abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5029%26epage%3D5042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Depression: a new animal model sensitive to antidepressant treatments</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1977&pages=730-732&author=R.+D.+Porsoltauthor=M.+Le+Pichonauthor=M.+Jalfre&title=Depression%3A+a+new+animal+model+sensitive+to+antidepressant+treatments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DLe%2BPichon%26aufirst%3DM.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DDepression%253A%2520a%2520new%2520animal%2520model%2520sensitive%2520to%2520antidepressant%2520treatments%26jtitle%3DNature%26date%3D1977%26volume%3D266%26spage%3D730%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Assessing antidepressant activity in rodents: recent developments and future needs</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=238-245&author=J.+F.+Cryanauthor=A.+Markouauthor=I.+Lucki&title=Assessing+antidepressant+activity+in+rodents%3A+recent+developments+and+future+needs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAssessing%2520antidepressant%2520activity%2520in%2520rodents%253A%2520recent%2520developments%2520and%2520future%2520needs%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D238%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0ljseBJ9Otkl9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Soumava Santra, Sandhya Kortagere, Seenuvasan Vedachalam, Sanjib Gogoi, Tamara Antonio, Maarten E.A. Reith, <span class="NLM_string-name hlFld-ContribAuthor">Aloke K. Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Potent Dopamine–Norepinephrine and Triple Reuptake Uptake Inhibitors Based on Asymmetric Pyran Template and Their Molecular Interactions with Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (8)
                                     , 1406-1418. <a href="https://doi.org/10.1021/acschemneuro.1c00078" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00078%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BPotent%252BDopamine%2525E2%252580%252593Norepinephrine%252Band%252BTriple%252BReuptake%252BUptake%252BInhibitors%252BBased%252Bon%252BAsymmetric%252BPyran%252BTemplate%252Band%252BTheir%252BMolecular%252BInteractions%252Bwith%252BMonoamine%252BTransporters%26aulast%3DSantra%26aufirst%3DSoumava%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09022021%26date%3D01042021%26date%3D12042021%26volume%3D12%26issue%3D8%26spage%3D1406%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Congxiang  Zha</span>, <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>, <span class="hlFld-ContribAuthor ">Min  Hu</span>, <span class="hlFld-ContribAuthor ">Wenge  Cui</span>, <span class="hlFld-ContribAuthor ">Yuh-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Ulhas  Bhatt</span>, <span class="hlFld-ContribAuthor ">Aruna  Sambandam</span>, <span class="hlFld-ContribAuthor ">Matthew  Isherwood</span>, <span class="hlFld-ContribAuthor ">Larry  Yet</span>, <span class="hlFld-ContribAuthor ">Michael T.  Herr</span>, <span class="hlFld-ContribAuthor ">Sarah  Ebeltoft</span>, <span class="hlFld-ContribAuthor ">Carla  Hassler</span>, <span class="hlFld-ContribAuthor ">Linda  Fleming</span>, <span class="hlFld-ContribAuthor ">Anthony D.  Pechulis</span>, <span class="hlFld-ContribAuthor ">Anne  Payen-Fornicola</span>, <span class="hlFld-ContribAuthor ">Nicholas  Holman</span>, <span class="hlFld-ContribAuthor ">Dennis  Milanowski</span>, <span class="hlFld-ContribAuthor ">Ian  Cotterill</span>, <span class="hlFld-ContribAuthor ">Vadim  Mozhaev</span>, <span class="hlFld-ContribAuthor ">Yuri  Khmelnitsky</span>, <span class="hlFld-ContribAuthor ">Peter R.  Guzzo</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Sargent</span>, and <span class="hlFld-ContribAuthor ">Bruce F.  Molino</span>  , <span class="hlFld-ContribAuthor ">Richard  Olson</span>, <span class="hlFld-ContribAuthor ">Dalton  King</span>, <span class="hlFld-ContribAuthor ">Snjezana  Lelas</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Li</span>, <span class="hlFld-ContribAuthor ">Kim  Johnson</span>, <span class="hlFld-ContribAuthor ">Thaddeus  Molski</span>, <span class="hlFld-ContribAuthor ">Anitra  Orie</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Roy  Haskell</span>, <span class="hlFld-ContribAuthor ">Wendy  Clarke</span>, <span class="hlFld-ContribAuthor ">Robert  Bertekap</span>, <span class="hlFld-ContribAuthor ">Jonathan  O’Connell</span>, <span class="hlFld-ContribAuthor ">Nicholas  Lodge</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">Robert  Zaczek</span>, and <span class="hlFld-ContribAuthor ">John E.  Macor</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of 4-Heteroaryl 1,2,3,4-Tetrahydroisoquinolines as Triple Reuptake Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (7)
                                     , 760-765. <a href="https://doi.org/10.1021/ml500053b" title="DOI URL">https://doi.org/10.1021/ml500053b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500053b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500053b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B4-Heteroaryl%252B1%25252C2%25252C3%25252C4-Tetrahydroisoquinolines%252Bas%252BTriple%252BReuptake%252BInhibitors%26aulast%3DLiu%26aufirst%3DShuang%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31012014%26date%3D13052014%26date%3D27052014%26date%3D10072014%26date%3D13052014%26volume%3D5%26issue%3D7%26spage%3D760%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Shu-Song  Ying</span>, <span class="hlFld-ContribAuthor ">Hong-Hong  Zheng</span>, <span class="hlFld-ContribAuthor ">Yan-Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Zhong-Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Hu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xu  Deng</span>, <span class="hlFld-ContribAuthor ">Yi-Jing  Wu</span>, <span class="hlFld-ContribAuthor ">Xiu-Mei  Gao</span>, <span class="hlFld-ContribAuthor ">Tian-Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan-Tong  Xu</span>, <span class="hlFld-ContribAuthor ">Hong-Hua  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel serotonin transporter regulators: Natural aristolane- and nardosinane- types of sesquiterpenoids from Nardostachys chinensis Batal. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-15483-6" title="DOI URL">https://doi.org/10.1038/s41598-017-15483-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-15483-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-15483-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DNovel%252Bserotonin%252Btransporter%252Bregulators%25253A%252BNatural%252Baristolane-%252Band%252Bnardosinane-%252Btypes%252Bof%252Bsesquiterpenoids%252Bfrom%252BNardostachys%252Bchinensis%252BBatal%26aulast%3DChen%26aufirst%3DYing-Peng%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Horrick  Sharma</span>, <span class="hlFld-ContribAuthor ">Soumava  Santra</span>, <span class="hlFld-ContribAuthor ">Aloke  Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (17)
                                     , 2385-2406. <a href="https://doi.org/10.4155/fmc.15.134" title="DOI URL">https://doi.org/10.4155/fmc.15.134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.134%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTriple%252Breuptake%252Binhibitors%252Bas%252Bpotential%252Bnext-generation%252Bantidepressants%25253A%252Ba%252Bnew%252Bhope%25253F%26aulast%3DSharma%26aufirst%3DHorrick%26date%3D2015%26volume%3D7%26issue%3D17%26spage%3D2385%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>, <span class="hlFld-ContribAuthor ">Ram K.  Modukuri</span>, <span class="hlFld-ContribAuthor ">Seema  Singh</span>, <span class="hlFld-ContribAuthor ">K.  Bhaskara Rao</span>, <span class="hlFld-ContribAuthor ">G.  Aruna Teja</span>, <span class="hlFld-ContribAuthor ">Sampa  Gupta</span>, <span class="hlFld-ContribAuthor ">Shubha  Shukla</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new series of coumarin–aminopyran derivatives possessing potential anti-depressant-like activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (2)
                                     , 337-341. <a href="https://doi.org/10.1016/j.bmcl.2014.11.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.11.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.11.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252Bseries%252Bof%252Bcoumarin%2525E2%252580%252593aminopyran%252Bderivatives%252Bpossessing%252Bpotential%252Banti-depressant-like%252Bactivity%26aulast%3DSashidhara%26aufirst%3DKoneni%2BV.%26date%3D2015%26volume%3D25%26issue%3D2%26spage%3D337%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>, <span class="hlFld-ContribAuthor ">Soumava  Santra</span>, <span class="hlFld-ContribAuthor ">Horrick  Sharma</span>, <span class="hlFld-ContribAuthor ">Chandrashekhar  Voshavar</span>, <span class="hlFld-ContribAuthor ">Liping  Xu</span>, <span class="hlFld-ContribAuthor ">Omar  Mabrouk</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, . </span><span class="cited-content_cbyCitation_article-title">Pharmacological and Behavioral Characterization of D-473, an Orally Active Triple Reuptake Inhibitor Targeting Dopamine, Serotonin and Norepinephrine Transporters. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , e113420. <a href="https://doi.org/10.1371/journal.pone.0113420" title="DOI URL">https://doi.org/10.1371/journal.pone.0113420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0113420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0113420%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DPharmacological%252Band%252BBehavioral%252BCharacterization%252Bof%252BD-473%25252C%252Ban%252BOrally%252BActive%252BTriple%252BReuptake%252BInhibitor%252BTargeting%252BDopamine%25252C%252BSerotonin%252Band%252BNorepinephrine%252BTransporters%26aulast%3DDutta%26aufirst%3DAloke%2BK.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3De113420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Horrick  Sharma</span>, <span class="hlFld-ContribAuthor ">Soumava  Santra</span>, <span class="hlFld-ContribAuthor ">Joy  Debnath</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten  Reith</span>, <span class="hlFld-ContribAuthor ">Aloke  Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (1)
                                     , 311-324. <a href="https://doi.org/10.1016/j.bmc.2013.11.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.11.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.11.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFlexible%252Band%252Bbiomimetic%252Banalogs%252Bof%252Btriple%252Buptake%252Binhibitor%252B4-%252528%252528%252528%2525283S%25252C6S%252529-6-benzhydryltetrahydro-2H-pyran-3-yl%252529amino%252529methyl%252529phenol%25253A%252BSynthesis%25252C%252Bbiological%252Bcharacterization%25252C%252Band%252Bdevelopment%252Bof%252Ba%252Bpharmacophore%252Bmodel%26aulast%3DSharma%26aufirst%3DHorrick%26date%3D2014%26volume%3D22%26issue%3D1%26spage%3D311%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soumava  Santra</span>, <span class="hlFld-ContribAuthor ">Sanjib  Gogoi</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Gopishetty</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Juan  Zhen</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Exploration of (3
              S
              ,6
              S
              )-6-Benzhydryl-
              N
              -benzyltetrahydro-2
              H
              -pyran-3-amine Analogues: Identification of Potent Triple Monoamine Reuptake Inhibitors as Potential Antidepressants. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2012,</strong> <em>7 </em>
                                    (12)
                                     , 2093-2100. <a href="https://doi.org/10.1002/cmdc.201200352" title="DOI URL">https://doi.org/10.1002/cmdc.201200352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201200352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201200352%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructural%252BExploration%252Bof%252B%2525283%252BS%252B%25252C6%252BS%252B%252529-6-Benzhydryl-%252BN%252B-benzyltetrahydro-2%252BH%252B-pyran-3-amine%252BAnalogues%25253A%252BIdentification%252Bof%252BPotent%252BTriple%252BMonoamine%252BReuptake%252BInhibitors%252Bas%252BPotential%252BAntidepressants%26aulast%3DSantra%26aufirst%3DSoumava%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D12%26spage%3D2093%26epage%3D2100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Solav  Ali</span>, <span class="hlFld-ContribAuthor ">Audrey  Hashim</span>, <span class="hlFld-ContribAuthor ">Imran S.  Sheikh</span>, <span class="hlFld-ContribAuthor ">Naresh  Theddu</span>, <span class="hlFld-ContribAuthor ">Narendra V.  Gaddiraju</span>, <span class="hlFld-ContribAuthor ">Suneet  Mehrotra</span>, <span class="hlFld-ContribAuthor ">Kyle C.  Schmitt</span>, <span class="hlFld-ContribAuthor ">Thomas F.  Murray</span>, <span class="hlFld-ContribAuthor ">Henry  Sershen</span>, <span class="hlFld-ContribAuthor ">Ellen M.  Unterwald</span>, <span class="hlFld-ContribAuthor ">Franklin A.  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Novel C-1 Substituted Cocaine Analogs Unlike Cocaine or Benztropine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2012,</strong> <em>343 </em>
                                    (2)
                                     , 413-425. <a href="https://doi.org/10.1124/jpet.112.193771" title="DOI URL">https://doi.org/10.1124/jpet.112.193771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.112.193771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.112.193771%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DNovel%252BC-1%252BSubstituted%252BCocaine%252BAnalogs%252BUnlike%252BCocaine%252Bor%252BBenztropine%26aulast%3DReith%26aufirst%3DMaarten%2BE.%2BA.%26date%3D2012%26date%3D2012%26volume%3D343%26issue%3D2%26spage%3D413%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Yong  Zheng</span>, <span class="hlFld-ContribAuthor ">Lin  Guo</span>, <span class="hlFld-ContribAuthor ">Xue-Chu  Zhen</span>, <span class="hlFld-ContribAuthor ">Jian-Qi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>54 </em>, 123-136. <a href="https://doi.org/10.1016/j.ejmech.2012.04.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.04.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.04.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantidepressant%252Bactivity%252Bof%252Barylalkanol-piperidine%252Bderivatives%252Bas%252Btriple%252Breuptake%252Binhibitors%26aulast%3DZheng%26aufirst%3DYong-Yong%26date%3D2012%26volume%3D54%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of known clinical and preclinical antidepressants.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular structures of lead asymmetric pyran TUIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) allylmagnesium chloride, ether, −78 °C to room temp, overnight, 82.4%; (b) ethylvinyl ether, Hg(OCOCF<sub>3</sub>)<sub>2</sub>, room temp, 4 h, 63.4%; (c) first generation Grubb's catalyst, benzene, reflux, 2 h, 67.6%; (d) (i) 9-BBN, THF, room temp, overnight; (ii) 10% NaOH, 30% H<sub>2</sub>O<sub>2</sub>, 50 °C, 1 h, 90%; (e) CH<sub>3</sub>SO<sub>2</sub>Cl, Et<sub>3</sub>N, dichloromethane, room temp, 2 h, 74.7% for <b>6a</b>, 12.4% for <b>6b</b>; (f) NaN<sub>3</sub>, DMF, 80 °C, overnight, 81.1%; (g) H<sub>2</sub>, Pd−C, MeOH, 50 psi, 2 h, quantitative yield.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) epoxide, EtOH, reflux, overnight.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RCHO, NaCNBH<sub>3</sub>, AcOH, 1,2-dichloroethane, room temp, overnight.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/medium/jm-2011-00020a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of subchronic administration of vehicle (10% β-hydroxypropylcyclodextrin solution), <b>10f</b>, and imipramine on the duration of immobility in the forced swimming test in rats. One-way ANOVA analysis demonstrated significant effect among treatments: <i>F</i>(4,95) = 13.70 (<i>P</i> < 0.008). Dunnett’s analysis showed that the effect of <b>10f</b> at 10 mg/kg dose on immobility was statistically significantly different compared to vehicle (<i>P</i> < 0.01). The effect of imipramine (15 mg/kg) on immobility was also statistically significantly different (<i>P</i> < 0.05) from vehicle. Asterisks indicate a statistically significant difference toward control group that received saline ip: (∗∗) <i>P</i> < 0.05 or 0.01. Each treatment group contained six to seven rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm200020a/production/images/large/jm-2011-00020a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200020a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kessler, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merikangas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span> </span><span class="NLM_article-title">The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=3095-3105&author=R.+C.+Kesslerauthor=P.+Berglundauthor=O.+Demlerauthor=R.+Jinauthor=D.+Koretzauthor=K.+R.+Merikangasauthor=A.+J.+Rushauthor=E.+E.+Waltersauthor=P.+S.+Wang&title=The+epidemiology+of+major+depressive+disorder%3A+results+from+the+National+Comorbidity+Survey+Replication+%28NCS-R%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DR.%2BC.%26aulast%3DBerglund%26aufirst%3DP.%26aulast%3DDemler%26aufirst%3DO.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DKoretz%26aufirst%3DD.%26aulast%3DMerikangas%26aufirst%3DK.%2BR.%26aulast%3DRush%26aufirst%3DA.%2BJ.%26aulast%3DWalters%26aufirst%3DE.%2BE.%26aulast%3DWang%26aufirst%3DP.%2BS.%26atitle%3DThe%2520epidemiology%2520of%2520major%2520depressive%2520disorder%253A%2520results%2520from%2520the%2520National%2520Comorbidity%2520Survey%2520Replication%2520%2528NCS-R%2529%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D3095%26epage%3D3105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lopez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. C.</span><span> </span><span class="NLM_article-title">The global burden of disease, 1990−2020</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1038%2F3218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=9809543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaK1cXntlantbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1241-1243&author=A.+D.+Lopezauthor=C.+C.+Murray&title=The+global+burden+of+disease%2C+1990%E2%88%922020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of disease, 1990-2020</span></div><div class="casAuthors">Lopez, Alan D.; Murray, Christopher C. J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1241-1243</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokLX9wB0X4L7Vg90H21EOLACvtfcHk0lhPD3GfAt0Ucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlantbk%253D&md5=788b34ec83f13b3b659d42d6479087cf</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F3218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F3218%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DA.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BC.%26atitle%3DThe%2520global%2520burden%2520of%2520disease%252C%25201990%25E2%2588%25922020%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1241%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Dilsaver, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swann, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoaib, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K. J.</span><span> </span><span class="NLM_article-title">Suicidality in patients with pure and depressive mania</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1312</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1176%2Fajp.151.9.1312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=8067486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A280%3ADyaK2czks1Ghuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1994&pages=1312-1315&author=S.+C.+Dilsaverauthor=Y.+W.+Chenauthor=A.+C.+Swannauthor=A.+M.+Shoaibauthor=K.+J.+Krajewski&title=Suicidality+in+patients+with+pure+and+depressive+mania"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Suicidality in patients with pure and depressive mania</span></div><div class="casAuthors">Dilsaver S C; Chen Y W; Swann A C; Shoaib A M; Krajewski K J</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1312-5</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  A previous comprehensive literature review indicated that suicide accounted for 18.9% of the deaths of 9,389 individuals with manic-depressive illness.  The literature associates these deaths with the depressed phase of the disease.  This study was designed to determine the rate and severity of suicidality among patients with pure and depressive mania.  METHOD:  The patients were 93 persons who met the Research Diagnostic Criteria (RDC) for bipolar I disorder (N = 75) or schizoaffective disorder (N = 18).  All met the RDC for primary mania and the DSM-III-R criteria for bipolar disorder, manic or mixed.  Patients with depressive mania met the RDC for mania and major depressive disorder concurrently.  Severity of current suicidality was measured by using the Schedule for Affective Disorders and Schizophrenia suicide subscale.  Differences in the mean suicidality scores between any two groups were assessed with the Kruskal-Wallis test.  Relationships of age, gender, type of affective illness (bipolar I versus schizoaffective disorder), psychosis, race, and mania subtype to suicidality were assessed by using multivariate logistic regression analysis.  RESULTS:  One (2.0%) of the 49 patients with pure mania was suicidal.  In contrast, 24 (54.5%) of the 44 patients with depressive mania were suicidal.  This difference was highly significant.  Gender and psychosis were not related to suicidality.  African-Americans were less likely to be suicidal than Caucasians.  Subtype of mania had the strongest relationship to suicidality.  CONCLUSIONS:  A subgroup of manic patients are severely suicidal.  Presentation in the manic state is an indication for careful assessment of depressive symptoms and suicidality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTStpF6EVmx9669lAbTj9rGfW6udTcc2ebwmxij83TAwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2czks1Ghuw%253D%253D&md5=8661ce0365cd77beeda92744beaf25bd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1176%2Fajp.151.9.1312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.151.9.1312%26sid%3Dliteratum%253Aachs%26aulast%3DDilsaver%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BW.%26aulast%3DSwann%26aufirst%3DA.%2BC.%26aulast%3DShoaib%26aufirst%3DA.%2BM.%26aulast%3DKrajewski%26aufirst%3DK.%2BJ.%26atitle%3DSuicidality%2520in%2520patients%2520with%2520pure%2520and%2520depressive%2520mania%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1994%26volume%3D151%26spage%3D1312%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Strakowski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, P. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. A.</span><span> </span><span class="NLM_article-title">Suicidality among patients with mixed and manic bipolar disorder</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1176%2Fajp.153.5.674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=8615413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A280%3ADyaK283gsFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1996&pages=674-676&author=S.+M.+Strakowskiauthor=S.+L.+McElroyauthor=P.+E.+Keckauthor=S.+A.+West&title=Suicidality+among+patients+with+mixed+and+manic+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Suicidality among patients with mixed and manic bipolar disorder</span></div><div class="casAuthors">Strakowski S M; McElroy S L; Keck P E Jr; West S A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-6</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Patients with mixed or manic bipolar disorder were studied to determine whether suicidality in mania is associated with increasing depression in general (i.e., a dimensional construct based on symptom severity) or with the presence of a mixed state per se (i.e., a categorical construct requiring the presence of a full depressive syndrome).  METHOD:  Diagnostic (categorical) assessments of 91 consecutively hospitalized patients with DSM-III-R mixed or manic bipolar disorder were made by using the Structural Clinical Interview for DSM-III-R.  Symptom (dimensional) assessments were made by using the Hamilton Depression Rating Scale, the Young Mania Rating Scale, and the Scale of the Assessment of Positive Symptoms.  Logistic regression models were employed to test the relative associations between suicidality and dimensional and categorical depression measures.  Receiver operating characteristics analysis was performed to identify a potential threshold depression rating that predicted suicidality.  RESULTS:  Suicidality was more common in mixed than manic bipolar disorder.  However, when adjusted for total depression scores, this association with affective state did not persist, but the statistical model significantly improved.  In the improved model, depressive symptom ratings were significantly associated with suicidality.  Hamilton depression scale ratings greater than 18 identified over 90% of the patients with suicidality, although there was also a high rate of false positives (32%).  CONCLUSIONS:  It is the severity of concurrent depressive symptoms in mania, rather than the presence of a depressive syndrome per se (i.e., mixed state), that is associated with suicidality in bipolar patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEOePgHccaLdenUz0lpNqnfW6udTcc2ebwmxij83TAwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283gsFaktQ%253D%253D&md5=72c7ec9930cfe187f9f09fa4ac346263</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1176%2Fajp.153.5.674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.153.5.674%26sid%3Dliteratum%253Aachs%26aulast%3DStrakowski%26aufirst%3DS.%2BM.%26aulast%3DMcElroy%26aufirst%3DS.%2BL.%26aulast%3DKeck%26aufirst%3DP.%2BE.%26aulast%3DWest%26aufirst%3DS.%2BA.%26atitle%3DSuicidality%2520among%2520patients%2520with%2520mixed%2520and%2520manic%2520bipolar%2520disorder%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1996%26volume%3D153%26spage%3D674%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Psychopharmacology of affective disorders in the 21st century</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2FS0006-3223%2898%2900068-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=9787875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=517-525&author=C.+B.+Nemeroff&title=Psychopharmacology+of+affective+disorders+in+the+21st+century"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Psychopharmacology of affective disorders in the 21st century</span></div><div class="casAuthors">Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-525</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 24 refs. Over the past several years, remarkable advances have been made in the understanding of both the central nervous system and the pathophysiol. of the major psychiatric disorders, resulting in major breakthroughs in capacity to treat these devastating illnesses.  Since the seminal work of Ramon Y Cajal and Golgi at the turn of the century, new techniques such as fluorescence histochem. have evolved into immunohistochem. and more recently in situ hybridization.  These techniques have permitted, for the 1st time, the elucidation of chem. defined neural circuits.  Such advances in the mapping of neural systems and the visualization of monoaminergic and peptidergic neurons and their receptors in tissue sections have provided the tools for the burgeoning field of neurochem. pathol. of psychiatric disorders.  Data from such studies have served as the basis for the development of novel pharmacol. approaches to the treatment of affective and anxiety disorders, as well as schizophrenia.  This review focuses on 2 major neural systems implicated in the pathophysiol. of depression: serotonin and corticotropin-releasing factor (CRF).  Development of novel agents are described, including selective serotonin receptor agonists, combined selective serotonin receptor antagonists and serotonin reuptake inhibitors, CRF receptor antagonists, and the use of an antisense strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe1Gcb06NIcLVg90H21EOLACvtfcHk0ljz_PJXbogRpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWksLw%253D&md5=4547cd80b997c1d00a5c20cd0536a329</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900068-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900068-7%26sid%3Dliteratum%253Aachs%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DPsychopharmacology%2520of%2520affective%2520disorders%2520in%2520the%252021st%2520century%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D517%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Iversen, L.</span><span> </span><span class="NLM_article-title">Neurotransmitter transporters: fruitful targets for CNS drug discovery</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1038%2Fsj.mp.4000728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=10889545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslGjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=357-362&author=L.+Iversen&title=Neurotransmitter+transporters%3A+fruitful+targets+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter transporters: fruitful targets for CNS drug discovery</span></div><div class="casAuthors">Iversen, L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-362</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 32 refs.  More than 20 members have been identified in the neurotransmitter transporter family.  These include the cell surface re-uptake mechanisms for monoamine and amino acid neurotransmitters and vesicular transporter mechanisms involved in neurotransmitter storage.  The norepinephrine and serotonin re-uptake transporters are key targets for antidepressant drugs.  Clin. effective antidepressants include those with selectivity for either NE or serotonin uptake, and compds. with mixed actions.  The dopamine transporter plays a key role in mediating the actions of cocaine and the amphetamines and in conferring selectivity on dopamine neurotoxins.  The only clin. used compd. to come so far from research on amino acid transporters is the antiepileptic drug tiagabine, a GABA uptake inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqYwFD8Vu3i7Vg90H21EOLACvtfcHk0ljz_PJXbogRpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslGjtLo%253D&md5=792cb672e96aa7b2cf541c27218924c7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4000728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4000728%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%26atitle%3DNeurotransmitter%2520transporters%253A%2520fruitful%2520targets%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DMol.%2520Psychiatry%26date%3D2000%26volume%3D5%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Schloss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. C.</span><span> </span><span class="NLM_article-title">The serotonin transporter: a primary target for antidepressant drugs</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1177%2F026988119801200201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=9694022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=115-121&author=P.+Schlossauthor=D.+C.+Williams&title=The+serotonin+transporter%3A+a+primary+target+for+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin transporter: a primary target for antidepressant drugs</span></div><div class="casAuthors">Schloss, Patrick; Williams, D. Clive</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-121</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">SAGE Publications</span>)
        </div><div class="casAbstract">A review with over 60 refs.  The serotoninergic system is known to modulate mood, emotion, sleep and appetite and thus is implicated in the control of numerous behavioral and physiol. functions.  Decreased serotoninergic neurotransmission has been proposed to play a key role in the etiol. of depression.  The concn. of synaptic serotonin is controlled directly by its reuptake into the pre-synaptic terminal and, thus, drugs blocking serotonin transport have been successfully used for the treatment of depression.  In addn. to tricyclic antidepressants (TCAs; e.g. imipramine) which also block noradrenaline reuptake, highly specific serotonin reuptake inhibitors (SSRIs) such as fluoxetine and paroxetine have been developed, which are increasingly prescribed for depressed patients.  The mode of action of these antidepressant drugs on their direct target, the serotonin transport protein, and possible regulatory mechanisms with respect to long-term alleviation of depression, although having been investigated both neurobiol. and clin. over the last years, are not yet understood.  The cloning of the cDNA encoding the serotonin transporter has allowed a more precise characterization of this protein at the mol. level.  This will show how antidepressants act at this target, thereby affecting the biochem., pharmacol. and electrophysiol. properties of the serotoninergic system and give an introduction of how they might exert their therapeutic effect.  This review gives an overview of the recent developments in this field, discusses mechanisms of antidepressant action on this target, and also possible interactions with other components of serotoninergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVjZAiA8RSW7Vg90H21EOLACvtfcHk0ljz_PJXbogRpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGmt7c%253D&md5=cc605d7200cca439749f26e2bb284091</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1177%2F026988119801200201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988119801200201%26sid%3Dliteratum%253Aachs%26aulast%3DSchloss%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26atitle%3DThe%2520serotonin%2520transporter%253A%2520a%2520primary%2520target%2520for%2520antidepressant%2520drugs%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D1998%26volume%3D12%26spage%3D115%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amsterdam, J. D.</span><span> </span><span class="NLM_article-title">Treatment-resistant depression: definition and treatment approaches</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><div class="note"><p class="first last">; discussion 48−50</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=2112132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A280%3ADyaK3c3ntVaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1990&pages=39-47&issue=Suppl.&author=A.+A.+Nierenbergauthor=J.+D.+Amsterdam&title=Treatment-resistant+depression%3A+definition+and+treatment+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment-resistant depression: definition and treatment approaches</span></div><div class="casAuthors">Nierenberg A A; Amsterdam J D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical psychiatry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">51 Suppl</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-47; discussion 48-50</span>
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    </div><div class="casAbstract">Little systematic attention has been directed toward the subject of treatment-resistant depression.  Although these patients constitute a distinct minority, their treatment consumes a major portion of the clinician's time.  Thus, the authors address the problems of defining and treating the estimated 750,000 patients with treatment-resistant depression.  Several major factors concerning treatment-resistant depression appear evident: (1) although there is an emerging consensus of what constitutes "adequate" treatment, the majority of patients receive suboptimal drug regimens; (2) misdiagnosis of depression subtypes can lead to suboptimal treatment and "pseudo-resistance" to drug therapy; (3) treatment strategies for resistant depression should use systematic algorithms to avoid confusion and limit "therapeutic nihilism" in the patient and physician; and (4) the patient's risk/benefit ratio for each successive treatment application must be considered with the potential benefit weighed against the increasing risk of illness morbidity and likelihood of adverse events and/or suicide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRl0pdntjAgiub6AVA-44PTfW6udTcc2ebrtvT12q_WTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ntVaktA%253D%253D&md5=9833159b4ea0d28c0bf54839271554b1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DAmsterdam%26aufirst%3DJ.%2BD.%26atitle%3DTreatment-resistant%2520depression%253A%2520definition%2520and%2520treatment%2520approaches%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1990%26volume%3D51%26issue%3DSuppl%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quitkin, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span> </span><span class="NLM_article-title">Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1012-1018&author=A.+A.+Nierenbergauthor=F.+M.+Quitkinauthor=C.+Kremerauthor=M.+B.+Kellerauthor=M.+E.+Thase&title=Placebo-controlled+continuation+treatment+with+mirtazapine%3A+acute+pattern+of+response+predicts+relapse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DQuitkin%26aufirst%3DF.%2BM.%26aulast%3DKremer%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DM.%2BB.%26aulast%3DThase%26aufirst%3DM.%2BE.%26atitle%3DPlacebo-controlled%2520continuation%2520treatment%2520with%2520mirtazapine%253A%2520acute%2520pattern%2520of%2520response%2520predicts%2520relapse%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1012%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">D’Aquila, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessa, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, G.</span><span> </span><span class="NLM_article-title">The role of dopamine in the mechanism of action of antidepressant drugs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2FS0014-2999%2800%2900566-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=11033341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Sitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=365-373&author=P.+S.+D%E2%80%99Aquilaauthor=M.+Colluauthor=G.+L.+Gessaauthor=G.+Serra&title=The+role+of+dopamine+in+the+mechanism+of+action+of+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of dopamine in the mechanism of action of antidepressant drugs</span></div><div class="casAuthors">D'Aquila, P. S.; Collu, M.; Gessa, G. L.; Serra, G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">365-373</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with >100 refs.  The present paper reviews evidence on the effect of antidepressant treatments on dopamine transmission.  Chronic treatment with antidepressant drugs potentiates the behavioral stimulant responses elicited by the stimulation of dopamine receptors, including reward-related behaviors.  Moreover, antidepressants affect dopamine release in several brain areas.  The reviewed literature is discussed in terms of the possible mechanisms underlying antidepressant-induced supersensitivity to dopamine-mediated behavioral responses, and of the possible implications for the therapeutic effect of these drugs.  It is concluded that the potentiation of dopaminergic neurotransmission induced by chronic antidepressant treatments might contribute to their therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRApOdl32jcbVg90H21EOLACvtfcHk0liFKDTQgpi3nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Sitbk%253D&md5=8ad7e0a9f61e0f36c2860e7be53ecb11</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900566-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900566-5%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Aquila%26aufirst%3DP.%2BS.%26aulast%3DCollu%26aufirst%3DM.%26aulast%3DGessa%26aufirst%3DG.%2BL.%26aulast%3DSerra%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520dopamine%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520antidepressant%2520drugs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D405%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Papakostas, G. I.</span><span> </span><span class="NLM_article-title">Dopaminergic-based pharmacotherapies for depression</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.euroneuro.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=16413172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=391-402&author=G.+I.+Papakostas&title=Dopaminergic-based+pharmacotherapies+for+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dopaminergic-based pharmacotherapies for depression</span></div><div class="casAuthors">Papakostas, George I.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">391-402</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The serendipitous discovery of the precursors of two of the major contemporary antidepressant families during the late 1950s, iproniazid for the monoamine oxidase inhibitors (MAOIs) and imipramine for the tricyclic antidepressants (TCAs), has guided the subsequent development of antidepressant compds. with predominantly serotonergic, noradrenergic or combined serotonergic and noradrenergic activity.  Unfortunately, however, many depressed patients continue to remain symptomatic despite adequate treatment with pharmacol. agents currently available.  When one reviews the list of pharmacol. agents currently approved for the treatment of Major Depressive Disorder (MDD), it is apparent that relatively few treatments with dopaminergic activity have been developed to date.  Therefore, developing effective antidepressant treatments with pro-dopaminergic properties which also possess a relatively wide safety margin may further improve the std. of care for depression.  In the present article we will briefly review studies focusing on the role of dopamine in depression followed by a comprehensive review of pharmacotherapies for depression with pro-dopaminergic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSaNt7Y60YLVg90H21EOLACvtfcHk0liFKDTQgpi3nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D&md5=d8c07a50f819444bf5d432b99f1d6af4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPapakostas%26aufirst%3DG.%2BI.%26atitle%3DDopaminergic-based%2520pharmacotherapies%2520for%2520depression%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D16%26spage%3D391%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Clayton, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnock, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornstein, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon-Keller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarvey, E. L.</span><span> </span><span class="NLM_article-title">A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.4088%2FJCP.v65n0110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=14744170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs12qsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=62-67&author=A.+H.+Claytonauthor=J.+K.+Warnockauthor=S.+G.+Kornsteinauthor=R.+Pinkertonauthor=A.+Sheldon-Kellerauthor=E.+L.+McGarvey&title=A+placebo-controlled+trial+of+bupropion+SR+as+an+antidote+for+selective+serotonin+reuptake+inhibitor-induced+sexual+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction</span></div><div class="casAuthors">Clayton, Anita H.; Warnock, Julia K.; Kornstein, Susan G.; Pinkerton, Relana; Sheldon-Keller, Adrienne; McGarvey, Elizabeth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-67</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">Objective: This study reports the results of a placebo-controlled, double-blind comparison of bupropion sustained release (SR) as an antidote for sexual dysfunction vs. placebo in 42 patients with selective serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction.  Exploratory analyses of the assocn. of testosterone and sexual functioning in women in the study were also performed.  Method: Patients with DSM-IV major depression who experienced a therapeutic response to any SSRI and were experiencing medication-induced global or phase-specific sexual dysfunction, as measured by the Changes in Sexual Functioning Questionnaire (CSFQ), were randomly assigned to receive either bupropion SR 150 mg b.i.d. or placebo for 4 wk in addn. to the SSRI.  Total testosterone levels were assessed at baseline and week 4.  Results: The difference in global sexual functioning, based on the total CSFQ score, was not statistically significant between the 2 groups at week 4, nor were differences in orgasm, desire/interest as measured by sexual thoughts, or self-reported arousal.  There was a statistically significant difference between the 2 groups at week 4 in desire as measured by self-report feelings of desire and frequency of sexual activity.  Desire/frequency showed a significantly greater improvement among those patients receiving bupropion SR compared with placebo (Wilk's F = 5.47, df = 1, p = .024).  Frequency was significantly correlated to total testosterone level at baseline (r = 0.36, p = .027) and at week 4 (r = 0.41, p =. 025).  Conclusions: Bupropion SR, as an effective antidote to SSRI-induced sexual dysfunction, produced an increase in desire to engage in sexual activity and frequency of engaging in sexual activity compared with placebo.  A larger study is needed to further investigate this finding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjsACDZkqu-rVg90H21EOLACvtfcHk0liFKDTQgpi3nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs12qsb4%253D&md5=42a907c58ae9f9e0360f2dab936cabb6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4088%2FJCP.v65n0110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v65n0110%26sid%3Dliteratum%253Aachs%26aulast%3DClayton%26aufirst%3DA.%2BH.%26aulast%3DWarnock%26aufirst%3DJ.%2BK.%26aulast%3DKornstein%26aufirst%3DS.%2BG.%26aulast%3DPinkerton%26aufirst%3DR.%26aulast%3DSheldon-Keller%26aufirst%3DA.%26aulast%3DMcGarvey%26aufirst%3DE.%2BL.%26atitle%3DA%2520placebo-controlled%2520trial%2520of%2520bupropion%2520SR%2520as%2520an%2520antidote%2520for%2520selective%2520serotonin%2520reuptake%2520inhibitor-induced%2520sexual%2520dysfunction%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2004%26volume%3D65%26spage%3D62%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Damsa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi-Demicheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidailhet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyenburg, S.</span><span> </span><span class="NLM_article-title">“Dopamine-dependent” side effects of selective serotonin reuptake inhibitors: a clinical review</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1064</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.4088%2FJCP.v65n0806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=15323590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFKhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=1064-1068&author=C.+Damsaauthor=A.+Bumbauthor=F.+Bianchi-Demicheliauthor=P.+Vidailhetauthor=R.+Sterckauthor=A.+Andreoliauthor=S.+Beyenburg&title=%E2%80%9CDopamine-dependent%E2%80%9D+side+effects+of+selective+serotonin+reuptake+inhibitors%3A+a+clinical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review</span></div><div class="casAuthors">Damsa, Cristian; Bumb, Anja; Bianchi-Demicheli, Francesco; Vidailhet, Pierre; Sterck, Robert; Andreoli, Antonio; Beyenburg, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1064-1068</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Neurophysiol. findings indicate an inhibition of dopaminergic neurotransmission by selective serotonin reuptake inhibitors (SSRIs).  This article highlights the relationships between changes in dopaminergic neurotransmission induced by SSRIs and the occurrence of certain side effects such as hyperprolactinemia, extrapyramidal symptoms, sexual and cognitive dysfunction, galactorrhea, mammary hypertrophy, and, more rarely, gynecomastia.  A systematic search of the literature in English, French, and German from 1980 to 2004 was performed in MEDLINE, EMBASE, and the Cochrane Library using the keywords SSRI, dopamine, serotonin, side effects, antidepressants, citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine, and nefazodone.  Refs. cited in all trials were searched iteratively to identify missing studies.  All studies concerning inhibition of dopaminergic neurotransmission by SSRIs and SSRI-related side effects were considered.  We retained 62 significant articles debating the subject.  We critically reviewed the studies, depending on the methodologies (case reports, clin. reports, randomized studies), and assessed the pertinence of "dopamine-dependent" SSRI-related side effects.  The analytic review of these articles suggests that some specific SSRI-related side effects be classified as dopamine-dependent.  At a clin. level, it could be useful to underline dopamine-dependent characteristics of some SSRI-related side effects.  This approach would allow clinicians the opportunity to search other dopamine-dependent side effects systematically.  At a pharmacol. level, this approach could stimulate the development of mols. with a "corrective" function on dopamine-dependent side effects of SSRIs by facilitating dopaminergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblfNLoRf397Vg90H21EOLACvtfcHk0ljcIcGCpS10ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFKhtrY%253D&md5=279e2ef460a4a62e5ed40cffc8b111fc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4088%2FJCP.v65n0806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v65n0806%26sid%3Dliteratum%253Aachs%26aulast%3DDamsa%26aufirst%3DC.%26aulast%3DBumb%26aufirst%3DA.%26aulast%3DBianchi-Demicheli%26aufirst%3DF.%26aulast%3DVidailhet%26aufirst%3DP.%26aulast%3DSterck%26aufirst%3DR.%26aulast%3DAndreoli%26aufirst%3DA.%26aulast%3DBeyenburg%26aufirst%3DS.%26atitle%3D%25E2%2580%259CDopamine-dependent%25E2%2580%259D%2520side%2520effects%2520of%2520selective%2520serotonin%2520reuptake%2520inhibitors%253A%2520a%2520clinical%2520review%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2004%26volume%3D65%26spage%3D1064%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2FS0014-2999%2803%2901310-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=12586204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2003&pages=99-104&author=P.+Skolnickauthor=P.+Popikauthor=A.+Janowskyauthor=B.+Beerauthor=A.+S.+Lippa&title=Antidepressant-like+actions+of+DOV+21%2C947%3A+a+%E2%80%9Ctriple%E2%80%9D+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor</span></div><div class="casAuthors">Skolnick, Phil; Popik, Piotr; Janowsky, Aaron; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">99-104</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">DOV 21,947 [(+)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride] inhibits the reuptake of [3H]serotonin, [3H]norepinephrine, and [3H]dopamine in human embryonic kidney (HEK) 293 cells expressing the corresponding human recombinant transporters (IC50 values of 12, 23, and 96 nM, resp.).  This compd. also inhibits [125I]RTI 55 (3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester) binding to the corresponding transporter proteins in membranes prepd. from these cells (Ki values of 99, 262, and 213 nM, resp.).  DOV 21,947 reduces the duration of immobility in the forced swim test (using rats) with an oral min. ED of 5 mg/kg.  This antidepressant-like effect manifests in the absence of significant increases in motor activity at doses of up to 20 mg/kg.  DOV 21,947 also produces a dose-dependent redn. in immobility in the tail suspension test, with a min. effective oral dose of 5 mg/kg.  The ability of DOV 21,947 to inhibit the reuptake of three biogenic amines closely linked to the etiol. of depression may result in a therapeutic profile different from antidepressants that inhibit the reuptake of serotonin and/or norepinephrine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Q0j1ranmerVg90H21EOLACvtfcHk0ljcIcGCpS10ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D&md5=6d48dc293c8237d42932da3effa40b8a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901310-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901310-4%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DAntidepressant-like%2520actions%2520of%2520DOV%252021%252C947%253A%2520a%2520%25E2%2580%259Ctriple%25E2%2580%259D%2520reuptake%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D461%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Shaw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">555</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.ejphar.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=17109850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFKhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2007&pages=30-36&author=A.+M.+Shawauthor=M.+Boulesauthor=Y.+Zhangauthor=K.+Williamsauthor=J.+Robinsonauthor=P.+R.+Carlierauthor=E.+Richelson&title=Antidepressant-like+effects+of+novel+triple+reuptake+inhibitors%2C+PRC025+and+PRC050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050</span></div><div class="casAuthors">Shaw, Amanda M.; Boules, Mona; Zhang, Yiqun; Williams, Katrina; Robinson, Jessica; Carlier, Paul R.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-36</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Most currently prescribed antidepressants act by selectively increasing the synaptic availability of serotonin or norepinephrine, or through action on both serotonin and norepinephrine.  However, most therapies require several weeks of treatment before improvement of symptoms is obsd. and not all patients respond to antidepressant treatment.  One strategy that has emerged in new antidepressant development is the use of triple reuptake inhibitors, which inhibit reuptake of serotonin, norepinephrine, and dopamine.  These compds. have been hypothesized to have a more rapid onset of activity and better efficacy over single or dual reuptake inhibitor antidepressants in part due to the addn. of the dopamine component.  The authors have developed novel compds. that are analogs of venlafaxine, of which two, racemic PRC025 ((2SR, 3RS)-N,N-dimethyl-3-cyclohexyl-3-hydroxy-2-(2'-naphthyl)propylamine) and PRC050 ((2RS,3RS)-N-methyl-3-hydroxy-2-(2'-naphthyl)-3-phenylpropylamine), are highly potent at human serotonin, norepinephrine, and dopamine transporters and inhibit the reuptake of serotonin, norepinephrine, and dopamine into rat brain synaptosomes.  These compds. were tested in animal models used to evaluate potential antidepressants: the forced swim test in rats and the tail suspension test in mice.  In the forced swim test, both PRC025 and PRC050 reduced the time spent immobile and increased the time spent swimming, comparable to the effects seen with imipramine, a tricyclic antidepressant.  In addn., both PRC025 and PRC050 were effective in reducing the time spent immobile in the tail suspension test, again with effects comparable to imipramine.  Therefore it appears that our compds. may possess antidepressant activity and represent a new class of triple reuptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNFgOGIhoBvLVg90H21EOLACvtfcHk0ljcIcGCpS10ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFKhtw%253D%253D&md5=27ba548eac72b50abedf771e55174fab</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BM.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAntidepressant-like%2520effects%2520of%2520novel%2520triple%2520reuptake%2520inhibitors%252C%2520PRC025%2520and%2520PRC050%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D555%26spage%3D30%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basile, A. S.</span><span> </span><span class="NLM_article-title">Triple reuptake inhibitors (“broad spectrum” antidepressants)</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.2174%2F187152707780363285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=17430151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltValtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=141-149&author=P.+Skolnickauthor=A.+S.+Basile&title=Triple+reuptake+inhibitors+%28%E2%80%9Cbroad+spectrum%E2%80%9D+antidepressants%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Triple reuptake inhibitors ("broad spectrum" antidepressants)</span></div><div class="casAuthors">Skolnick, Phil; Basile, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-149</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The majority of antidepressants in current use inhibit the uptake of serotonin and/or norepinephrine.  Drugs inhibiting the uptake of serotonin, norepinephrine and dopamine (triple reuptake inhibitors) may offer therapeutic advantages compared to single and/or dual reuptake inhibitors.  This review provides a rationale for developing this class of compd. and describes the results of preclin. and clin. studies with a family of triple reuptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnlyNGAigKoLVg90H21EOLACvtfcHk0ljcIcGCpS10ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltValtbo%253D&md5=f5bde2286f4f0cce3f911a47645a5c88</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F187152707780363285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707780363285%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DBasile%26aufirst%3DA.%2BS.%26atitle%3DTriple%2520reuptake%2520inhibitors%2520%2528%25E2%2580%259Cbroad%2520spectrum%25E2%2580%259D%2520antidepressants%2529%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D141%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briody, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1<i>S</i>,2<i>S</i>)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1124%2Fjpet.108.143610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=18689611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=573-583&author=Y.+Liangauthor=A.+M.+Shawauthor=M.+Boulesauthor=S.+Briodyauthor=J.+Robinsonauthor=A.+Oliverosauthor=E.+Blazarauthor=K.+Williamsauthor=Y.+Zhangauthor=P.+R.+Carlierauthor=E.+Richelson&title=Antidepressant-like+pharmacological+profile+of+a+novel+triple+reuptake+inhibitor%2C+%281S%2C2S%29-3-%28methylamino%29-2-%28naphthalen-2-yl%29-1-phenylpropan-1-ol+%28PRC200-SS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span></div><div class="casAuthors">Liang, Yanqi; Shaw, Amanda M.; Boules, Mona; Briody, Siobhan; Robinson, Jessica; Oliveros, Alfredo; Blazar, Eric; Williams, Katrina; Zhang, Yiqun; Carlier, Paul R.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-583</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Due to the putative involvement of dopaminergic circuits in depression, triple reuptake inhibitors are being developed as a new class of antidepressant, which is hypothesized to produce a more rapid onset and better efficacy than current antidepressants selective for serotonin or norepinephrine neurotransmission.  (1S,2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC 200SS), a new triple reuptake inhibitor, potently bound to the human serotonin, norepinephrine, and dopamine transporters with Kd values of 2.3, 0.63, and 18 nM, resp.  Inhibition of serotonin, norepinephrine, and dopamine uptake by PRC 200SS was also shown in cells expressing the corresponding transporter (Ki values of 2.1, 1.5, and 61 nM, resp.).  In vivo, PRC 200SS dose-dependently decreased immobility in the forced-swim test in rats and in the tail-suspension test in mice, models predictive of antidepressant activity, with effects comparable with imipramine.  These results in the behavioral models did not seem to result from the stimulation of locomotor activity.  Consistent with the in vitro data and behavioral effects, peripheral administration of PRC 200SS (5 and 10 mg/kg i.p.) significantly increased extracellular levels of serotonin and norepinephrine in the medial prefrontal cortex, and of serotonin and dopamine in the core of nucleus accumbens, with redn. of levels of 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid compared with levels for saline control.  Furthermore, PRC 200SS self-administration, which was used as a marker of abuse liability, was not obsd. with rats.  Therefore, it seems that PRC 200SS may represent a novel triple reuptake inhibitor and possess antidepressant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjq1Ko19NBbVg90H21EOLACvtfcHk0lhWA0pyR7_gQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ&md5=1cfb6ece94bf5fa1187219d03f676d09</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143610%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DA.%2BM.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DBriody%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DOliveros%26aufirst%3DA.%26aulast%3DBlazar%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAntidepressant-like%2520pharmacological%2520profile%2520of%2520a%2520novel%2520triple%2520reuptake%2520inhibitor%252C%2520%25281S%252C2S%2529-3-%2528methylamino%2529-2-%2528naphthalen-2-yl%2529-1-phenylpropan-1-ol%2520%2528PRC200-SS%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D573%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czobor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A.</span><span> </span><span class="NLM_article-title">Preclinical and clinical pharmacology of DOV 216,303, a “triple” reuptake inhibitor</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=123-134&author=P.+Skolnickauthor=P.+Krieterauthor=J.+Tizzanoauthor=A.+Basileauthor=P.+Popikauthor=P.+Czoborauthor=A.+Lippa&title=Preclinical+and+clinical+pharmacology+of+DOV+216%2C303%2C+a+%E2%80%9Ctriple%E2%80%9D+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DKrieter%26aufirst%3DP.%26aulast%3DTizzano%26aufirst%3DJ.%26aulast%3DBasile%26aufirst%3DA.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DCzobor%26aufirst%3DP.%26aulast%3DLippa%26aufirst%3DA.%26atitle%3DPreclinical%2520and%2520clinical%2520pharmacology%2520of%2520DOV%2520216%252C303%252C%2520a%2520%25E2%2580%259Ctriple%25E2%2580%259D%2520reuptake%2520inhibitor%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of novel 2,5-disubstituted cis- and trans-piperidine derivatives exhibiting differential activity for the dopamine transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2337</span><span class="NLM_x">–</span> <span class="NLM_lpage">2340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2337-2340&author=A.+K.+Duttaauthor=M.+C.+Davisauthor=M.+E.+Reith&title=Rational+design+and+synthesis+of+novel+2%2C5-disubstituted+cis-+and+trans-piperidine+derivatives+exhibiting+differential+activity+for+the+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520novel%25202%252C5-disubstituted%2520cis-%2520and%2520trans-piperidine%2520derivatives%2520exhibiting%2520differential%2520activity%2520for%2520the%2520dopamine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2337%26epage%3D2340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Expansion of structure−activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the <i>N</i>-benzyl moiety and behavioral pharmacology of selected molecules</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010316x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=654-662&author=A.+K.+Duttaauthor=M.+C.+Davisauthor=X.+S.+Feiauthor=P.+M.+Beardsleyauthor=C.+D.+Cookauthor=M.+E.+Reith&title=Expansion+of+structure%E2%88%92activity+studies+of+piperidine+analogues+of+1-%5B2-%28diphenylmethoxy%29ethyl%5D-4-%283-phenylpropyl%29piperazine+%28GBR+12935%29+compounds+by+altering+substitutions+in+the+N-benzyl+moiety+and+behavioral+pharmacology+of+selected+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm010316x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010316x%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DFei%26aufirst%3DX.%2BS.%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26aulast%3DCook%26aufirst%3DC.%2BD.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DExpansion%2520of%2520structure%25E2%2588%2592activity%2520studies%2520of%2520piperidine%2520analogues%2520of%25201-%255B2-%2528diphenylmethoxy%2529ethyl%255D-4-%25283-phenylpropyl%2529piperazine%2520%2528GBR%252012935%2529%2520compounds%2520by%2520altering%2520substitutions%2520in%2520the%2520N-benzyl%2520moiety%2520and%2520behavioral%2520pharmacology%2520of%2520selected%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D654%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ghorai, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1220</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020275k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1220-1228&author=S.+K.+Ghoraiauthor=C.+Cookauthor=M.+Davisauthor=S.+K.+Venkataramanauthor=C.+Georgeauthor=P.+M.+Beardsleyauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=High+affinity+hydroxypiperidine+analogues+of+4-%282-benzhydryloxyethyl%29-1-%284-fluorobenzyl%29piperidine+for+the+dopamine+transporter%3A+stereospecific+interactions+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm020275k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020275k%26sid%3Dliteratum%253Aachs%26aulast%3DGhorai%26aufirst%3DS.%2BK.%26aulast%3DCook%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DVenkataraman%26aufirst%3DS.%2BK.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DHigh%2520affinity%2520hydroxypiperidine%2520analogues%2520of%25204-%25282-benzhydryloxyethyl%2529-1-%25284-fluorobenzyl%2529piperidine%2520for%2520the%2520dopamine%2520transporter%253A%2520stereospecific%2520interactions%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1220%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolhatkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Dopamine transporter as target for drug development of cocaine dependence medications</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">479</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.ejphar.2003.08.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=14612141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=479&publication_year=2003&pages=93-106&author=A.+K.+Duttaauthor=S.+Zhangauthor=R.+Kolhatkarauthor=M.+E.+Reith&title=Dopamine+transporter+as+target+for+drug+development+of+cocaine+dependence+medications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transporter as target for drug development of cocaine dependence medications</span></div><div class="casAuthors">Dutta, Aloke K.; Zhang, Shijun; Kolhatkar, Rohit; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">479</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">93-106</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Because much evidence implicates the dopamine transporter in the reinforcing effects of cocaine, development of potential medications for cocaine dependence has included the dopamine transporter as a target.  The present overview covers progress in the drug development area regarding several classes of dopamine uptake inhibitors, with an emphasis on structure-activity relationships that enhance potency and selectivity at transporters for dopamine compared with those for serotonin or norepinephrine.  The following categories of compds. are covered: tropane, benztropine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR), methylphenidate, mazindol, and phencyclidine analogs.  Activity at transporters as well as on behavior is highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUvNoDOWGKRbVg90H21EOLACvtfcHk0lg1sCzSavvmzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGntLg%253D&md5=7a1ad0ab734b33159dcdde6c16785129</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2003.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2003.08.060%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKolhatkar%26aufirst%3DR.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DDopamine%2520transporter%2520as%2520target%2520for%2520drug%2520development%2520of%2520cocaine%2520dependence%2520medications%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D479%26spage%3D93%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1591-1595&author=S.+Zhangauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Design%2C+synthesis%2C+and+activity+of+novel+cis-+and+trans-3%2C6-disubstituted+pyran+biomimetics+of+3%2C6-disubstituted+piperidine+as+potential+ligands+for+the+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520activity%2520of%2520novel%2520cis-%2520and%2520trans-3%252C6-disubstituted%2520pyran%2520biomimetics%2520of%25203%252C6-disubstituted%2520piperidine%2520as%2520potential%2520ligands%2520for%2520the%2520dopamine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1591%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kolhatkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghorai, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structurally constrained analogues of <i>cis</i>-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5101</span><span class="NLM_x">–</span> <span class="NLM_lpage">5113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049796t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5101-5113&author=R.+Kolhatkarauthor=C.+D.+Cookauthor=S.+K.+Ghoraiauthor=J.+Deschampsauthor=P.+M.+Beardsleyauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structurally+constrained+analogues+of+cis-%286-benzhydrylpiperidin-3-yl%29benzylamine+with+elucidation+of+bioactive+conformation%3A+discovery+of+1%2C4-diazabicyclo%5B3.3.1%5Dnonane+derivatives+and+evaluation+of+their+biological+properties+for+the+monoamine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm049796t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049796t%26sid%3Dliteratum%253Aachs%26aulast%3DKolhatkar%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DC.%2BD.%26aulast%3DGhorai%26aufirst%3DS.%2BK.%26aulast%3DDeschamps%26aufirst%3DJ.%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structurally%2520constrained%2520analogues%2520of%2520cis-%25286-benzhydrylpiperidin-3-yl%2529benzylamine%2520with%2520elucidation%2520of%2520bioactive%2520conformation%253A%2520discovery%2520of%25201%252C4-diazabicyclo%255B3.3.1%255Dnonane%2520derivatives%2520and%2520evaluation%2520of%2520their%2520biological%2520properties%2520for%2520the%2520monoamine%2520transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5101%26epage%3D5113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of <i>cis</i>-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6301</span><span class="NLM_x">–</span> <span class="NLM_lpage">6315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=6301-6315&author=S.+Zhangauthor=J.+Zhenauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Structural+requirements+for+2%2C4-+and+3%2C6-disubstituted+pyran+biomimetics+of+cis-%286-benzhydryl-piperidin-3-yl%29-benzylamine+compounds+to+interact+with+monoamine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DStructural%2520requirements%2520for%25202%252C4-%2520and%25203%252C6-disubstituted%2520pyran%2520biomimetics%2520of%2520cis-%25286-benzhydryl-piperidin-3-yl%2529-benzylamine%2520compounds%2520to%2520interact%2520with%2520monoamine%2520transporters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D6301%26epage%3D6315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Discovery of novel trisubstituted asymmetric derivatives of (2<i>S</i>,4<i>R</i>,5<i>R</i>)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4962</span><span class="NLM_x">–</span> <span class="NLM_lpage">4971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049021k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4962-4971&author=S.+Zhangauthor=J.+Zhenauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Discovery+of+novel+trisubstituted+asymmetric+derivatives+of+%282S%2C4R%2C5R%29-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol%2C+exhibiting+high+affinity+for+serotonin+and+norepinephrine+transporters+in+a+stereospecific+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm049021k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049021k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDiscovery%2520of%2520novel%2520trisubstituted%2520asymmetric%2520derivatives%2520of%2520%25282S%252C4R%252C5R%2529-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol%252C%2520exhibiting%2520high%2520affinity%2520for%2520serotonin%2520and%2520norepinephrine%2520transporters%2520in%2520a%2520stereospecific%2520manner%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4962%26epage%3D4971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeldine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structural exploration of trisubstituted asymmetric pyran derivatives (2<i>S</i>,4<i>R</i>,5<i>R</i>)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3<i>S</i>,6<i>S</i>) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4239</span><span class="NLM_x">–</span> <span class="NLM_lpage">4247</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601699" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4239-4247&author=S.+Zhangauthor=F.+Fernandezauthor=S.+Hazeldineauthor=J.+Deschampsauthor=J.+Zhenauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structural+exploration+of+trisubstituted+asymmetric+pyran+derivatives+%282S%2C4R%2C5R%29-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol+and+their+corresponding+disubstituted+%283S%2C6S%29+pyran+derivatives%3A+a+proposed+pharmacophore+model+for+high-affinity+interaction+with+the+dopamine%2C+serotonin%2C+and+norepinephrine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0601699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601699%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DHazeldine%26aufirst%3DS.%26aulast%3DDeschamps%26aufirst%3DJ.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structural%2520exploration%2520of%2520trisubstituted%2520asymmetric%2520pyran%2520derivatives%2520%25282S%252C4R%252C5R%2529-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol%2520and%2520their%2520corresponding%2520disubstituted%2520%25283S%252C6S%2529%2520pyran%2520derivatives%253A%2520a%2520proposed%2520pharmacophore%2520model%2520for%2520high-affinity%2520interaction%2520with%2520the%2520dopamine%252C%2520serotonin%252C%2520and%2520norepinephrine%2520transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4239%26epage%3D4247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">589</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2Fj.ejphar.2008.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=18561912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVCmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=589&publication_year=2008&pages=73-79&author=A.+K.+Duttaauthor=B.+Ghoshauthor=S.+Biswasauthor=M.+E.+Reith&title=D-161%2C+a+novel+pyran-based+triple+monoamine+transporter+blocker%3A+behavioral+pharmacological+evidence+for+antidepressant-like+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">D-161, a novel pyran-based triple monoamine transporter blocker: Behavioral pharmacological evidence for antidepressant-like action</span></div><div class="casAuthors">Dutta, Aloke K.; Ghosh, Balaram; Biswas, Swati; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">589</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">73-79</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Deficiency in dopaminergic activity has been linked to a depressed state in pharmacol. and clin. studies.  Current pharmacol. treatment for depression primarily involves modulation of serotonergic and noradrenergic systems but not dopaminergic neurotransmission.  Available pharmacotherapy for depression has a no. of drawbacks as a significant no. of people are either refractory or develop tolerance to the antidepressant agents resulting in relapse.  Furthermore, the slow onset of action of current therapies often poses a challenge for effective treatment.  In our effort to develop novel mols. impacting all three above mentioned monoamine systems, we discovered structurally unique pyran derivs. with various profiles in inhibiting monoamine transporters.  One of our lead mols., D-161 exhibited triple monoamine transporter inhibitory activity with the highest affinity for norepinephrine transporter (NET) followed by its affinity for serotonin transporter (SERT) and dopamine transporter (DAT).  D-161 exhibited potent activity in reducing immobility significantly in the rat forced swim test as well as in the mouse tail suspension test.  Moreover, results from locomotor activity tests indicated that the redn. of immobility by D-161 was not due to motor activation as no significant motor activation was obsd. when the rats were subjected to the same doses of drug under the same conditions as in the forced swim test.  These results suggest that the novel asym. pyran deriv. D-161 with unique mol. structure exhibiting triple monoamine transporter inhibitory activity could possess potent antidepressant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqClWsN6M4N3bVg90H21EOLACvtfcHk0lh99J5uN02nIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVCmtL0%253D&md5=d1a459f96d53829ef5f484500ad524a8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DD-161%252C%2520a%2520novel%2520pyran-based%2520triple%2520monoamine%2520transporter%2520blocker%253A%2520behavioral%2520pharmacological%2520evidence%2520for%2520antidepressant-like%2520action%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D589%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsin, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5042</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990291q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5029-5042&author=D.+B.+Lewisauthor=D.+Mateckaauthor=Y.+Zhangauthor=L.+W.+Hsinauthor=C.+M.+Derschauthor=D.+Staffordauthor=J.+R.+Glowaauthor=R.+B.+Rothmanauthor=K.+C.+Rice&title=Oxygenated+analogues+of+1-%5B2-%28diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5Bbis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+potential+extended-action+cocaine-abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm990291q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990291q%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DOxygenated%2520analogues%2520of%25201-%255B2-%2528diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255Bbis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520potential%2520extended-action%2520cocaine-abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5029%26epage%3D5042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Depression: a new animal model sensitive to antidepressant treatments</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1977&pages=730-732&author=R.+D.+Porsoltauthor=M.+Le+Pichonauthor=M.+Jalfre&title=Depression%3A+a+new+animal+model+sensitive+to+antidepressant+treatments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DLe%2BPichon%26aufirst%3DM.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DDepression%253A%2520a%2520new%2520animal%2520model%2520sensitive%2520to%2520antidepressant%2520treatments%26jtitle%3DNature%26date%3D1977%26volume%3D266%26spage%3D730%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Assessing antidepressant activity in rodents: recent developments and future needs</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=238-245&author=J.+F.+Cryanauthor=A.+Markouauthor=I.+Lucki&title=Assessing+antidepressant+activity+in+rodents%3A+recent+developments+and+future+needs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAssessing%2520antidepressant%2520activity%2520in%2520rodents%253A%2520recent%2520developments%2520and%2520future%2520needs%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D238%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200020a&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200020a&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200020a&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lh99J5uN02nIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a href="/doi/suppl/10.1021/jm200020a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62331"></div></div></div></div></div><hr /></hr><p class="last">Spectral data for <b>6b</b>, binding affinity of <b>10f</b>, and elemental analysis data for all final targets. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200020a/suppl_file/jm200020a_si_001.pdf">jm200020a_si_001.pdf (55.58 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200020a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm200020a%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-8%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200020a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                956KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679915d30b752367","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
